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Killer-cell immunoglobulin-like receptor (KIR) gene frequencies have been shown to 
be distinctly different between populations and may be the basis for functional 
variation. We report the frequencies of 15 KIR genes (2DL1, 2DL2, 2DL3, 2DL4, 
2DL5, 2DS1, 2DS2, 2DS3, 2DS4, 2DS5, 3DL1, 3DL2, 3DL3, 3DS1 and KIR1D) and 
two pseudogenes (2DP1 and 3DP1) in three ethnic groups in Singapore. Four 
framework genes KIR3DL3, 3DP1, 2DL4 and 3DL2 and one non-framework 
pseudogene KIR2DP1 were found in all samples tested. The remaining 12 KIRs had 
frequencies that vary across three populations. KIR2DS2, 2DL2, 2DL5 and 2DS5 had 
the greatest significant variations.  
 
Ninety-eight distinct KIR profiles were determined in our populations, 51 of which 
were novel. Amongst the three populations, Singapore Indian had the highest 
frequencies of all the genes characteristic of B haplotypes and appearing more 
heterogeneous in genotypes. Analysis indicated that A haplotypes predominate in our 
populations, the ratio of A: B haplotypes were found to be approximately 3: 1, 2.4: 1 
and 1.3: 1 in Singapore Chinese, Malay and Indian respectively.  
 
Sixteen significant linkage disequilibria (LD), consistent with associations between A 
and B haplotypes genes, were observed. Positive LD among B haplotype genes were 
exhibited by KIR2DS2, 2DL2, 2DL5 and 2DS3; and KIR3DS1, 2DS5 and 2DS1, each 
of which was also positively associated with 2DL5. Two A haplotype genes KIR2DL1 
and 2DL3 were positively linked. Negative linkage disequilibria were observed 
between A haplotype gene KIR1D and B haplotype gene 2DS1; and A haplotype gene 
KIR3DL1 and B haplotype genes KIR2DS5 and 2DS1. 
 vii
Comparison of KIR frequencies showed that Singapore Chinese shared similar 
characteristics with frequencies reported by Chinese Han, Japanese and Korean; 
Singapore Indian showed similar distribution with that reported by north Indian 
Hindu; and Singapore Malay exhibited comparable frequencies with those published 
for the Thai. 
 
For haplotype studies, 19 distinct KIR genotypes and eight different haplotypes were 
identified in 40 individuals from 11 unrelated Singapore Chinese families. The 
distribution of genotypes, in terms of haplotypes, was AA 27.5%, AB 63.6% and BB 
9.1%. Nine different KIR haplotypes were resolved through segregation analysis 
based on established haplotype models. Haplotype A2 with 45.5% frequency 
prevailed in Singapore Chinese, comparable to Korean and Chinese Han. 
 
Case-control study was focused on Singapore Chinese in order to investigate the 
associations of KIR genes with nasopharyngeal carcinoma (NPC), a disease prevalent 
among Chinese populations. Activating KIR2DS2 showed significantly higher 
frequency whereas inhibitory 2DL1 exhibited significantly lower frequency in NPC 
patients compared to controls implying that KIR2DS2 and lack of KIR2DL1 may 
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The human leukocyte receptor cluster (LRC) is a region of ~1 
Mb in length located on chromosome 19q13.4, containing ILTs, 
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CHAPTER 1. LITERATURE REVIEW 
 
1.1 Killer-cell Immunoglobulin-like Receptors  
Killer-cell immunoglobulin-like receptors (KIRs) are cell surface receptors of the 
immunoglobulin (Ig) superfamily that are expressed on most natural killer (NK) cells 
and subsets of memory and effector T cells in humans.  KIRs interact with human 
leukocyte antigen (HLA) class I molecules on target cells.  Besides humans, KIRs 
have also developed in primates (Khakoo et al., 2000) and cows (McQueen et al., 
2002) but appear to be completely absent in rodents.  Receptors for HLA class I 
molecules in rodents are Ly49 molecules encoded by a multigene family within the 
natural killer gene complex (NKC) on rat chromosome 4 (Dissen et al., 1996) and 
mouse chromosome 6 (Yokohama et al., 1991).  KIRs are Ig-related molecules while 
Ly49 are C-type lectin-related proteins.  Human KIR and mouse Ly49 are functional 
analogues that have many genetic similarities, although they are from different 
structural families (Trowsdale et al., 2001).  It is suspected that humans evolved from 
an ancestral species containing Ly49 genes, since the single Ly49 pseudogene is 
present within the NKC on human chromosome 12 (Barter and Trowsdale, 1999). 
 
1.1.1 KIR Genes 
Human KIRs are type I glycoproteins encoded by a family of closely linked and 
highly polymorphic genes clustered in a region called the leukocyte receptor complex 
(LRC) on chromosome 19q13.4 (Fig 1.1) (Baker et al., 1995; Dupont et al., 1997; 
Wende et al., 1999).  The LRC spans about 1 Mb of chromosome 19q13.4 and 
contains families of genes that encode receptors in which the extracellular domains 
are made up of Ig-like domains (Canavez et al., 2001).  KIR genes are arranged in 
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head-to-tail fashion two-kilo base pairs (kb) apart with just one unique section 14-kb 
upstream of the 2DL4 locus (Wilson et al., 2000).  Each gene is roughly 10-16 kb in 
length; the gene family thus occupies about 150 kb of the LRC.  Besides KIR loci, the 
LRC incorporates genes that encode other members of the Ig superfamily, including 
Ig-like transcript (ILT), leukocyte-associated Ig-like receptor (LAIR), Fc receptor for 
Ig A (FcαR) and natural cytotoxicity receptor gene NKp46.  The KIR loci are 
bordered by ILT at the centromeric side and FcαR at the telomeric end.  Like the 
NKC, the LRC has a syntenic region defined in the mouse, located on chromosome 6, 

















Fig 1.1 The human leukocyte receptor cluster (LRC) is a region of ~1 Mb in 
length located on chromosome 19q13.4, containing ILTs, LAIRs, KIRs, FcαR and 
NKp46 genes. 3DL3, 3DP1, 2DL4 and 3DL2 (in black) are framework KIR genes. 
Note: This figure is not drawn to scale and the number of bars does not represent 











So far, 17 KIR genes and pseudogenes have been identified, including 2DL1, 2DL2, 
2DL3, 2DL4, 2DL5, 2DS1, 2DS2, 2DS3, 2DS4, 2DS5, 3DL1, 3DL2, 3DL3, 3DS1, 
2DP1, 3DP1 and KIR1D.  Over a hundred KIR sequences have been deposited into 
either the GenBank or the European Molecular Biology Laboratory (EMBL) 
nucleotide sequence databases.  KIR sequences differed by less than 2% from the 
consensus sequence of a particular KIR gene would be designated as alleles of that 
gene (Carrington and Norman, 2003). 
 
1.1.2 KIR Nomenclature 
The Human Genome Nomenclature Committee (HGNC) assigned and approved 
nomenclature to KIR genes.  The KIR nomenclature is stored and maintained in the 
HGNC database (www.gene.ucl.ac.uk/nomenclature/genefamily/kir.html).  The 
names given to the KIR genes are based on the structures of the molecules they 
encode.  According to this generally accepted nomenclature system, the acronym KIR 
that stands for Killer-cell Ig-like Receptor is followed by a suffix that describes the 
molecule.  The number of extracellular Ig-like domains is indicated by either 2D for 
‘2 domains’ or 3D for ‘3 domains’; the letter L or S denotes that either they have long 
(L) or short (S) cytoplasmic tails in the intracellular region, or a ‘P’ for pseudogene; 
and finally a code number indicates the number of the gene encoding a protein with 
this structure. 
 
KIR molecules occur in two different forms, inhibitory and activating.  KIRs with 
long cytoplasmic domains (L) are inhibitory by the virtue of two immunoreceptor 
tyrosine-based motifs (ITIMs) present in the cytoplasmic domain (Long, 1999).  In 
this motif, a large hydrophobic residue such as isoleucine or valine occurs two 
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residues upstream of a tyrosine that is followed by two amino acids and a leucine to 
give the amino acid sequence ...[I/V]XYXXL...  ITIMs permit the transduction of 
inhibitory signals (Long, 1999).  The presence of short cytoplasmic domains (S) 
devoid of ITIMs but contain a charged amino acid residue in the transmembrane 
domain corresponds to the activating KIRs (Vivier and Daeron, 1997; Wilson et al., 
1997). The charged amino acid residue in the transmembrane domain mediates 
interaction with activation protein in the cytotoxicity pathway (Vivier and Daeron, 
1997; Wilson et al., 1997). 
 
For instance, KIR2DS1 is an activating receptor that contains two Ig-like domains 
and a short cytoplasmic tail while KIR3DL1 is an inhibitory receptor with three Ig-
like domains and a long cytoplasmic tail.  One unusual KIR is 2DL4, which contains 
signature features of both inhibitory and activating receptors for having two 
extracellular Ig-like domains; a long cytoplasmic tail with only one ITIM; and a 
charged amino acid in the transmembrane region. 
 
KIR2DP1, also known as KIRZ, KIR15, KIRY and KIR2DL6, is closely related to 
KIR2DL2/L3 and 2DL1, with more than 97% homology at the nucleotide level and 
contains two pseudo exons.  KIR3DP1, also known as CD158c, KIR48, KIRX and 
KIR2DS6, is severely truncated and an alternate form of the gene is differentiated by a 
1.5-kb deletion, which removes exon 2 (Wilson et al., 2000).  KIR2DP1 and 3DP1 are 
considered pseudogenes or silent genes because their RNA is normally undetected in 
peripheral blood mononuclear cells.  However, a recombinant allele designated 
KIR3DP1*004 preceded by a novel promoter was recently identified and believed to 
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be a functional gene at least in the Caucasian population (Gomez-Lozano et al., 
2005).  The allele is predicted to encode a secreted protein.  
 
1.1.3 Exon-intron Structure of KIR Genes 
The exon-intron structure of various KIR genes is justly consistent. The basic 
arrangements of exons encoding various domains of a KIR molecule are as the 
following: first two exons encode for the signal peptide; exons 3-5 corresponds to 
each Ig-like domains (D0, D1 and D2 starting from the N terminal), exons 6 and 7 
encode the linker region and the transmembrane region respectively; and two final 
exons encode the cytoplasmic tail.  
 
KIR2DL1, 2DL2, 2DL3 and all 2DS genes are known as type 1 two-domain KIR 
genes, which have a genomic organization similar to KIR3D genes that encode KIR 
molecules with three Ig-like domains.  However, the exon 3 is a pseudoexon, which 
remains in-frame but is eventually spliced out, possibly due to a three-base-pair 
deletion.  Their protein products are therefore lacking the D0 domain. KIR2DL4 and 
2DL5 are type 2 two-domain KIRs characterized by the absence of exon 4 and 
therefore their protein products have no D1 domain.  The KIR3DL3 gene closely 
resembles other KIR3D genes except that it is missing exon 6.  
 
Pseudogene KIR2DP1 has exon-intron structure similar to that of the type 1 two-
domain genes but contain two pseudo exons 3 and 4.  It is truncated in comparison 
with all other KIRs.  It has exons 1-5 of other KIR3D gene but lacks of exons 6, 7, 8, 
and 9 that encode the linker, transmembrane and cytoplasmic domains.  For 
pseudogene KIR3DP1, two of its alleles (KIR3DP1*00301 and *00302) lack exon 2 
 7
in addition to exons 6-9, due to a 1.5-kb deletion. Another allele, KIR3DP1*004, 
contains exon 6 in addition to exons 1-5.  For this recombinant allele, exons 1-5 is 
expected to encode leader sequence and D0, D1 and D2 Ig-like domains and exon 6 is 
predicted to encode a tail instead of the stem, transmembrane and cytoplasmic regions 
seen in other KIRs.  Thus its protein product is unable to function as a membrane 
receptor and might be a secreted to the extracellular medium (Gomez-Lozano et al., 
2005).  
 
1.2 Ligands for KIRs 
Some of the classical and non-classical HLA class I molecules have been identified to 
be the ligands of several KIRs. HLA are molecules that participate in the adaptive 
anti-pathogen defense by presenting peptide to immune effector cells.  KIR 
recognizes HLA molecules with locus and allele specificity (Lanier and Philips, 
1996), although KIR expression is not influenced by HLA class I ligands due to 
independent segregation of these two gene families on different human chromosomes 
(Becker et al., 2003).  However, a study in mice showed that NK cells can be 
‘educated’ by MHC class I molecules (Johansson et al., 2005).  Experiment with 
MHC class I transgenic mice have demonstrated that NK cells were capable of 
recognizing loss of any self MHC class I molecules in vivo (Johansson et al., 2005). 
 
1.2.1 Ligands for Inhibitory KIRs 
HLA-C molecules are the predominant ligands for most inhibitory KIRs (Fig 1.2). 
They are divided into two groups based on the amino acid 80 in the α-1 helix of HLA 
molecules.  KIR2DL2 and 2DL3 are found to interact directly with HLA-C group 1 
allotypes including Cw1, 3, 7, 8, 12, 13, 14, 1507 and 1601, characterized by the 
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presence of asparagine at position 80.  KIR2DL1 interacts directly with HLA-C group 
2 allotypes including Cw2, 4, 5, 6, 707, 12042, 15, 1602 and 17, characterized by the 
presence of lysine at position 80 (Colonna and Samaridis, 1995; Moretta et al., 1995). 
Specificity for HLA-C is defined by amino acid at position 44 of KIR2D. Crystal 
structures of the interaction between HLA-C molecules and KIR2DL1 (Fan et al., 
1997), 2DL2 (Snyder et al., 1999; Jeffrey et al., 2001) and 2DL3 (Maenaka et al., 
1999) are available.  KIR is found to interact, via D1 and D2 domains, directly with 
the α1 and α2 helixes of HLA molecules as well as the bound peptide, which also 
plays a part in KIR binding (Mandelboim et al., 1997; Young et al., 1998; Jeffrey et 






Fig 1.2 Inhibitory KIR receptors on NK cells recognize HLA class I molecules on 
target cells. Absence of cognate HLA ligand on target cells enable the activation of 
NK cell. KIR2DL2 and 2DL3 recognize HLA-C alleles characterized by Asn80 
(HLA-CAsn80), such as the Cw3 group. KIR2DL1 recognizes HLA-C alleles 
characterized by Lys80 (HLA-CLys80), such as the Cw4 group. KIR3DL1 recognizes 
HLA alleles expressing the serologic Bw4 epitope (Dupont and Hsu, 2004). 
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It is clear that multiple HLA alleles can be recognized by the same KIR receptor. 
There are significantly more HLA alleles than there are KIR receptors.  KIR 
recognizes more than one MHC allele by recognizing the conserved residues within 
the polymorphic regions of the MHC.  In addition, KIR exhibits exact specificity for 
particular MHC allotypes through variation at a single KIR residue at position 44 
(Jeffrey et al., 2001).  This variation is sufficient to differentiate between 
polymorphisms found at position 80 of the HLA-C heavy chain.  In this situation, 
KIR2DL1 that has a Met at position 44 recognizes HLA-C allotypes with Lys at 
position 80.  KIR2DL2, on the other hand, containing a Lys at position 44, does not 
recognize HLA-C molecules with Lys at position 80.  Instead, it recognizes HLA-C 
molecules with Asn at position 80.  The interface residues of different KIR receptors, 
such as KIR2DL2 and 2DL3 that recognize the same HLA molecules are completely 
conserved.  
 
Crystal structure of KIR2DL2/HLA-Cw3 complex revealed by Jeffrey et al. (2001) 
detailed the interaction between the two molecules that bind in 1:1 stoichiometry.  
The interaction was observed to be a rigid one, consistent with rapid binding kinetics 
and the favorable entropic contributions because there were no significant 
conformational changes either in KIR2DL2 or HLA-Cw3 when the complex was 
compared to its unbound components (Jeffrey et al., 2001).  The KIR/HLA interface 
was characterized by strong charge complementary contributed by six acidic residues 
in KIR that interact with six basic residues in HLA (Jeffrey et al., 2001).  
 
KIR3DL1 specifically recognizes HLA-Bw4 allotypes that express the serological 
Bw4 epitope (Fig 1.2) (D’Andrea et al., 1995; Grumperz et al., 1995) characterized by 
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an isoleucine residue found at position 80.  HLA genes that express the Bw4 epitope 
include HLA-B5, B5102, B5103, B13,B17, B27, B37, B38, B44, B47, B49, B51, 
B52, B53, B57, B58, B59, B63, B77, A9, A23, A24, A25 and A32. KIR3DL2 
interacts with certain HLA-A allotypes such as *03 and *11 (Valiante et al., 1997a). 
KIR2DL4, the unique KIR that possesses both inhibitory and activating features, 
probably recognizes the non-classical HLA-G (Cantoni et al., 1998; Rajagopalan et 
al., 1999) that is specifically expressed on human trophoblasts.  The ligands for 
KIR2DL5 and KIR3DL3 remain unknown thus far.  
 
1.2.2 Ligands for Activating KIRs 
In contrast to what is known for many inhibitory KIRs, ligand specificity for 
activating KIRs remain elusive.  Although the extracellular sequences of the 
activating KIRs and the corresponding inhibitory KIRs differ only slightly, the 
ligands of activating KIRs have not yet been clearly defined.  For instance, although 
KIR3DS1 have ligand-binding domain that are highly similar to that of KIR3DL1, 
there is no direct evidence that this activating receptor share the same HLA-B Bw4 
ligand as its inhibitory counterpart.  Similarly obscure are the ligand specificity for 
KIR2DS1, 2DS2, 2DS3, 2DS4 and 2DS5.  Activating receptors tend to recognize 
their ligands with lower affinity than that of closely related inhibitory counterparts 
(Vales-Gomez et al., 1998; Vales-Gomez et al., 1999).  Although KIR2DS1 and 2DS2 
exhibit weak binding to HLA-C group 2 and HLA-C group 1 respectively in vitro, it 
is not clear that these are their physiological ligands.  
 
This lead to speculations that activating receptors might be truly specific for HLA 
when class I levels are high or they may recognize non-MHC molecules such as 
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pathogen-derived peptide presented by MHC class I molecules or viral antigens 
(Lanier, 2001).  In the mouse Ly49 receptor family, the activating Ly49H and the 
inhibitory Ly49I receptors bind to the m157 protein of murine cytomegalovirus 
(Arase et al., 2002; Smith et al., 2002), suggesting that KIRs may also have viral 
protein ligands. It is also possible that activating KIRs have ligand-independent 
functions.  It is important to determine ligand specificity of inhibitory and activating 
KIRs in order to interpret genetic correlation with diseases.  
 
1.3 Expression of KIR 
Both stimulatory and inhibitory KIR genes are expressed by NK cells and a subset of 
T cells (Colonna and Samaridis, 1995; Wagtmann et al., 1995a).  Receptors are 
expressed in a clonally distributed fashion and many NK cells in an individual share 
the same repertoire of receptors (Valiante et al., 1997a; Long, 1999).   Clonal NK cell 
expression of KIR genes is largely determined by KIR genotype, with little or no 
influence from HLA (Miller and McCullar, 2001; Shilling et al., 2002b), as KIR can 
be expressed for which there is no HLA ligand and vice-versa.  Within a person’s NK 
cell population the expression of KIR is very heterogenous due to the expression of 
different number and combinations of KIR genes.  This variable expression results in 
subsets of NK cells with different MHC class I specificity.  However, Johansson and 
co-workers (2005) had proposed the existence of an educational process that control 
proper missing self-surveillance in vivo.  They had demonstrated that novel NK cell 




In a similar way, T cells are clonally distinct in their receptor expression pattern (Vely 
et al., 2001).  About 5% of human peripheral blood memory CD8+ T cells express 
KIR genes (Mingari et al., 1996).  KIR molecules expressed on T cells can regulate 
effector functions such as cytokine release and target cell cytolysis (Mingari et al., 
1998). 
 
All human NK cells express at least one KIR gene and all of the KIR genes in a 
person’s genotype are expressed by some of that person’s NK cells.  KIR, being the 
main component of NK cell repertoire of receptor expression, has contributions from 
both inhibitory and activating receptors.  Inhibitory KIR contributes to tolerance 
whereas the activating KIR contributes to killing of infected cells.  All KIR genes in a 
person’s NK receptor repertoire are expressed except pseudogenes KIR3DP1, 2DP1 
and possibly the 3DL3 gene (Valiante et al., 1997a).  A selection process, which 
mechanism is unknown, is in place to insure that each NK cell express at least one 
inhibitory receptor specific for self HLA class I molecule while they may or may not 
express an activating receptor.  In mice, the ability of NK cells to reject cells lackig 
MHC class I molecules results form an education process (Joansson et al., 2005).  In 
case an NK cell lacks all of the major inhibitory KIRs, it will express the 
heterodimeric inhibitory receptor CD94-NKG2A (Valiante et al., 1997b), which binds 
to the non-classical HLA-E. 
 
1.4 The ‘Missing Self’ Hypothesis 
NK cells are an important component of the innate immunity, which mediate an 
immediate immune response that precedes adaptive immune responses.  Their 
presence and activity is readily detectable in peripheral blood, and to a lesser extend, 
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in lymphoid organs.  They circulate in the blood as partially activate effector cells that 
are able to response immediately to infection.  They are called natural killer cells 
because they exhibit spontaneous killing against target cells without the need for 
antigen-specific activation.  
 
NK cells express a broad array of inhibiting and activating KIRs.  The interaction of 
KIRs with HLA class I molecules on target cells provides critical regulation of human 
NK cytotoxicity (Moretta et al., 1993; D’Andrea et al., 1996).  The effector function 
of NK cells are regulated by a dynamic balance between positive and negative signals 
delivered by these and other membrane receptors that control their ability to mediate 
target cell lysis and produce cytokines to stimulate other cells in the immune system 
in response to immune challenge (Lanier, 1997).  
 
Under most circumstances, inhibitory KIRs help NK cells to prevent reactivity against 
self healthy cells and protect them by spontaneous destruction by interacting with 
different HLA alleles on normal cells (Long et al., 2001).  Although neither the direct 
mode of NK cell action nor the ligands of many KIRs is known, it is believed that 
healthy cells are spared from spontaneous killing when they express an appropriate 
ligand for inhibitory receptors expressed by cytotoxic cells.  
 
By contrast, HLA interaction with inhibitory receptors may not occur with virus-
infected, transformed or tumor cells, because their surface HLA class I molecules are 
either altered in number or reduced in expression.  Cytotoxic T lymphocyte-mediated 
recognition and elimination of viral peptides in an MHC class I restricted fashion is 
an essential part of the immune response to viral infections.  Therefore it is not 
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surprising that different pathogens have evolved a variety of strategies to interfere 
with antigen processing, peptide presentation and MHC class I expression in order to 
prevent antigen from being presented (Fruh et al., 1997).  However, although some 
viruses can suppress surface HLA expression by the cell they infect to escape the 
adaptive immune responses by T cells, this render the cells better targets for 
destruction by NK cells at an early stage, promoted and mediated by activation 
receptors such as KIRs, NCRs and NKG2D.  
 
This observation leads to the formulation of the ‘missing self’ hypothesis of NK cell 
recognition proposed by Karre et al. (1986), which stated that loss of target cell HLA 
removed the ligands for inhibitory NK receptors, resulting in NK cell activation and 
target cell lysis (Fig 1.3) (Karre et al., 1986; Ljunggren et al., 1990).  Target cells for 
NK cell-directed destruction include transformed tumor cells, virus-infected cells and 
cells undergoing other types of “stress” (Vilches and Parham, 2002; Young et al., 
2002).  Upon HLA binding to activating KIRs, the charged residue in the 
transmembrane domain of the KIR receptor interacts with a negatively charged 
residue of the adaptor molecule DNAX activation protein (DAP12), serving to 
stabilize the interaction between these two proteins.  DAP12 is an adaptor protein that 
contains an Immunoreceptor Tyrosine-based Activation Motif (ITAM) in the 
cytoplasmic domain.  Cross-linking of KIR-DAP12 complex leads to recruitment and 
activation of several SH2-domain containing protein tyrosine kinases such as of ZAP-
70 and Syk, and adaptor molecules coupling to downstream process of intracellular 




1.5 KIR Diversity 
The KIR gene family is highly diverse and rapidly evolving.  KIR exhibits extensive 
haplotypic diversity, due to gene number and component (Uhrberg et al., 1997; 
Wilson et al., 2000; Yawata et al., 2002b) as well as allelic polymorphism at the 
individual KIR gene (Selvakumar et al., 1997; Shilling et al., 1998; Steffens et al., 
1998; Gardiner et al., 2001; Rajalingam et al., 2001).  In addition, each NK cell 
carries its own repertoire of KIRs.  As a consequence of the effect of these 
components of diversity, the probability of two unrelated individuals possessing 







Fig 1.3 Activating and inhibitory KIRs expressed on NK cells provide 
surveillance for MHC loss. NK cells simultaneously expressing activating KIR2DS 
receptor for HLA-C and inhibitory KIR3DL receptor for HLA-Bw4 would not harm 
normal cell, which co-express HLA-C and HLA-Bw4, because inhibitory KIR would 
inactivate positive signals induced by activating KIR molecule. However, transformed 
or virus-infected cell that had lost expression of HLA-Bw4 would be recognized as 
abnormal and attacked, lead to cell lysis (Ravetch and Lanier, 2000). 
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Haplotype or polygenic diversity characterized by a defined set of genes in an 
individual determines the specificity range of NK cell response of that individual 
(Uhrberg, 2005).  In contrast, allelic polymorphism generally affects the expression 
levels of a given KIR and in turn regulates the detection of down-regulated HLA class 
I on target cell and onset of activation (Uhrberg, 2005).  
 
To date, over 110 profiles of KIR sequences haven been identified from genotyping 
and many distinct haplotypes from family segregations have been reported 
(Carrington and Norman, 2003).  The numbers are expected to continue to grow, as 
more unrelated individuals as well as families are screened.  
 
1.5.1 Allelic Polymorphism 
Variation can occur throughout the KIR gene including at sites encoding residues that 
affects binding to HLA molecules.  Most KIR loci have multiple alleles. So far, three 
pairs of genes including KIR3DS1 and 3DL1 (Gardiner et al., 2001); KIR2DL2 and 
2DL3 (Witt et al., 1999; Crum et al., 2000); and KIR2DS4 and KIR1D (Hsu et al., 
2002b) have been suggested to segregate as alleles of the same locus and appear on 
the same position on different haplotypes.  Previously, KIR2DS4 and 2DS1 were 
suggested to be alleles (Uhrberg et al., 1997), but have been proved to be distinct 
genes that occupy two different loci (Wilson et al., 2000; Norman et al., 2001). 
KIR1D is a 2DS4 gene variant identified by Hsu et al (Hsu et al., 2002b).  It appeared 
as a consequence of a 22-bp deletion in the coding region of the KIR2DS4, resulting 
in disruption of the second extracellular Ig-like domain (D2) and leading to a frame 
shift and a premature stop codon, with a putative protein product truncated within the 
transmembrane domain (Hsu et al., 2002b).  It was designated KIR1D because of the 
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high degree of similarity in amino acid sequence with the rhesus monkey KIR1D, 
which suggests that they are functional orthologs.  
 
Allelic polymorphism in KIRs is likely to be generated by unequal recombination, 
duplication events, unequal crossovers, alternative RNA splicing and point mutations 
(Dohring et al., 1996; Shilling et al., 1998; Khakoo et al., 2000; Martin et al., 2004). 
All these mechanisms contribute to the abundant variability in KIR haplotypes. 
 
1.5.2 Haplotype Diversity 
Two groups of KIR haplotypes are defined and termed A and B, as proposed by 
Uhrberg et al. (1997) based on PCR typing and restriction fragment length 
polymorphism analysis.  These two groups of haplotypes are initially differentiated by 
the presence of a 24 kb HindIII fragment on Southern blot analysis (Uhrberg et al., 
1997).  Group A and B haplotypes can be distinguished on the basis of several 
features.  Group A haplotypes have been defined as containing the minimum number 
of loci including KIR2DL1, 2DL3, 2DL4, 2DS4, 3DL1, 3DL2, 3DL3, 2DP1 and 
3DP1.  Group A haplotypes are devoid of activating genes except KIR2DS4. While 
they do not vary in gene content, they show extensive variability on the allelic level 
(Shilling et al., 2002a). 
 
In contrast, group B haplotypes contain more than one activating gene, including 
various combinations of KIR2DS1, 2DS2, 2DS3, 2DS5, 3DS1 and 2DS4.  Perhaps 
functionally more important, the gene content is biased towards activating genes, 
which can vary in number from two to five.  While they show substantial variation in 
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gene content as they possess more genes than A haplotypes do, they only exhibit 
moderate allelic polymorphism.  
 
Although KIR haplotypes vary in gene number and content, three conserved blocks 
are common to all haplotypes.  They comprise of KIR3DL3 at the centromeric end; 
KIR3DP1 (3DP1*00302 on A haplotypes and 3DP1*002 on B haplotypes) and 
KIR2DL4 within the central region of the gene cluster; and KIR3DL2 at the telomeric 
end.  These genes are the framework loci that are present in all haplotypes (Wilson et 
al., 2000).  The number of genes between framework genes varies.  Recently, with 
KIR2DS4 and KIR1D clearly distinguished as two different alleles, the broad 
classification of haplotypes into two groups have been reassessed by Hsu et al. 
(2002b), whereby the group A haplotype is further divided into two subgroups, one 
containing KIR2DS4 and the other containing KIR1D in association with KIR3DP1. 
The latter subtype is far more common, comprising 73% of the group A haplotype in 
the Caucasian (Hsu et al., 2002b).  
 
An alternative model describes KIR haplotype as two separate halves, the centromeric 
half margined upstream with KIR3DL3 and comprised of genes upstream of 
framework locus 2DL4; while the telomeric half comprised of genes downstream of 
KIR2DL4 and bordered downstream by 3DL2 (Hsu et al., 2002a).  The centromeric 
half is characterized by the presence of KIIR2DL2 or 2DL3, but not both, and rarely, 
neither.  When present, KIR2DL2 is always paired with 2DS2 whereas 2DL3 usually 
pair with the trio of 2DP1, 2DL1 and 3DP1 (Hsu et al., 2002a).  The telomeric half is 
defined by the presence of KIR3DL1 or 3DS1, and rarely neither.  There are two 
different combinations of genes that describe the telomeric half, which give rise to a 
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short or long segment.  The presence of KIR3DL1 denotes the short telomeric 
fragment containing 2DS1, 2DS4 or KIR1D and bordered by 3DL2 at the end.  In 
contrast, the presence of KIR3DS1 designates the long fragment, which contain the 
2DL5 paired with either 2DS3 or 2DS5, followed by the locus occupied by 2DS1, 
2DS4 or KIR1D.  This locus is then bordered by KIR3DL2 at the end of the segment 
(Hsu et al., 2002a).  In general, haplotypes that have been described so far fit into the 
model developed by Hsu et al, except some rare haplotypes, which may be explained 
by recombination, gene duplication and inversion. 
 
Linkage disequilibrium (LD) studies revealed strong allelic disequilibria between 
pairs of genes on the centromeric side and pairs of genes on the telomeric side 
(Shilling et al., 2002a).  LD is the phenomenon of non-random association between 
alleles at linked genetic loci.  LD patterns in general correspond to the physical 
distance between KIR genes, there appears to be greater LD between genes within 
each half than there is between the two halves (Hsu et al., 2002b; Shilling et al., 
2002a).  
 
Comparison of human populations shows that KIR gene frequencies as well as KIR 
haplotypes exhibit considerable specificity and divergence across different ethnic 
groups in the world.  The relative frequency of A and B haplotypes is almost equal in 
the Caucasian population (Hsu et al., 2002a).  In other populations such as Japanese 
(Yawata et al., 2002a) and Korean (Whang et al., 2005), group A haplotype 
dominates, whereas group B haplotype predominates in Australian Aborigines 
(Toneva et al., 2001).  A possible hypothesis of this level of diversity is that the ratio 
of A and B haplotypes diverged subsequent to the separation of these populations in 
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response to different selection pressure, probably due to locally acting 
epidemiological challenges. 
 
1.6 Disease Associations with KIRs 
NK cells have been implicated in defense against infection, presumably by involving 
KIR receptors as well as their ligands.  Given the receptor-ligand relationship between 
KIR and HLA, it is reasonable to hypothesize a combined effect between these two 
families of gene in regulating NK cell responses against pathogens.  Studies on 
association of HLA, KIR or combination of both with various diseases have begun. 
To date, HLA class I molecules and KIRs have been implicated in disease 
development and advancement in different clinical areas as diverse as reproduction, 
autoimmune disease, infectious disease and cancer and haematopoietic stem cell 
transplantation.   
 
1.6.1 KIR and Reproduction 
HLA-G, the putative ligand of KIR2DL4 is almost exclusively expressed during 
pregnancy by extravillous trophoblasts and can influence NK cell interaction with 
trophoblast.  Interaction between maternal NK cells and fetal trophoblasts is crucial in 
placental formation and blood supply.  Insufficient placental blood supply can lead to 
a serious condition called pre-eclampsia, which in turn leads to eclampsia that can be 
fatal to both mother and child.  Association of KIR2DL4 alleles with pre-eclampsia 
had been studied.  However, result of study indicated no significant differences in 
KIR2DL4 alleles frequencies and KIR gene repertoire between 45 women who had 
pre-eclampsia and 48 normotensive controls (Witt et al., 2002).  By contrast, a recent 
study revealed that the combination of maternal homozygosity for group A KIR 
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haplotye and fetal HLA-C2 predisposes pregnant women to pre-eclampsia (Hiby et 
al., 2004).  The possible engagement of HLA-C molecule with inhibitory KIR2DL1 
receptor of the A haplotype is expected to provide the strongest inhibition (Parham, 
2005).  This ligand-receptor combination could overly inhibit NK cell, which in turn 
under stimulate the trophoblasts and leads to pre-eclampsia (Hiby et al., 2004). 
However, the effect of HLA-C2 inhibition can be offset by the presence of activating 
KIR genes (Parham, 2005).  Thus, the risk of pre-eclampsia is reduced by the presence 
of group B haplotype genes.  For instance, the weak interaction between activating 
KIR2DS1 and HLA-C2 might generate activating signals that mute the inhibitory 
signal from KIR2DL1. 
 
1.6.2 KIR and Infectious Diseases 
NK cell responses and association of KIR genes with infectious diseases such as 
hepatitis, AIDS and malaria had been reported.  Study on cohorts of hepatitis C virus 
(HCV)-infected individuals from United States of America (U.S.A.) and the United 
Kingdom (U.K.) revealed that individuals homozygous for genes encoding both 
inhibitory KIR2DL3 and its HLA-C1 allotypes favored resolution of acute HCV 
infection (Khakoo et al., 2004).  This receptor-ligand combination is believed to give 
the weakest NK cell inhibition (Parham, 2005), less restriction on NK cells thus leads 
to desirable effects on patients. 
 
AIDS patients who have both KIR3DS1 genes and a HLA-B allele with the Bw4 motif 
showed delayed disease progression after HIV infection (Martin et al., 2002a).  The 
HLA-B allele alone in the absence of KIR3DS1 is not associated with AIDS whereas 
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3DS1 in the absence of the HLA-B allele was largely associated with rapid 
progression to AIDS (Martin et al., 2002a).  
 
NK-cell response to malaria parasite Plasmodium falciparum was studied by in vitro 
culture of peripheral-blood mononuclear cells with parasite-infected red blood cells 
(Artavanis-Tsakonas et al., 2003).  There was wide dissimilarity in the ability of NK 
cells to form conjugates with infected erythrocytes and produce IFN-γ among a panel 
of healthy, non-immune blood donors.  Correlation with KIR genotype of the donor 
showed a tendency for high responders to have the KIR3DL2*002 allele (Artavanis-
Tsakonas et al., 2003). 
 
1.6.3 KIR and Autoimmune Diseases 
Several stimulatory KIR genes have been associated with susceptibility to several 
autoimmune diseases such as psoriasis and psoriatic arthritis, conditions that have 
long been associated with HLA-C.  Psoriasis is a chronic inflammatory skin disease. A 
study of psoriasis reported that combination of KIR2DS1 and HLA-Cw*06 increase 
susceptibility compared to either factor alone (Luszczek et al., 2004).  Another study 
found an association of two B haplotype genes, KIR2DS1 and 2DL5 that are in 
linkage, with increased risk to the disease in the Japanese population (Suzuki et al., 
2004).   
 
For psoriatic arthritis, a study reported that activating KIR2DS1 and/or 2DS2 genes 
are associated with susceptibility to psoriatic arthritis, but only when HLA ligands for 
their homologous inhibitory receptors, KIR2DL1 and 2DL2/3, are absent (Martin et 
al., 2002b).  Lack of ligands for inhibitory KIRs could potentially lower the threshold 
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for NK cytotoxicity mediated through activating receptors, thereby contributing to 
disease development (Martin et al., 2002b).  Similarly, other studies showed that an 
increase in activating KIR-HLA ligand pairs combined with a lack of inhibitory KIR-
ligand pairs were associated with higher risk of diabetes (Silk et al., 2003) and 
scleroderma (Momot et al., 2004).  
 
1.6.4 KIR and Haematopoietic Stem Cell Transplantation 
Recent studies have analyzed the outcome of haematopoietic stem cell transplantation 
(HCT) in donor-recipient pairs with known HLA and KIR genotypes.  In one study of 
the HLA-mismatched pairs, acute myelogenous leukemia (AML) patients undergoing 
HLA-identical HCT lacking ligands for donor inhibitory KIRs exhibited better overall 
survival and decreased incidence of relapse (Ruggeri et al., 1999).  In KIR ligand 
incompatibility, a transient alloreaction mediated by NK cells from the donor can 
arise during the first few months after transplantation.  Such alloreactive cells can 
provide protection against tumor relapse and graft-versus-host disease in AML 
patients but not acute lymphoblastic leukemia (Ruggeri et al., 1999).  This gave rise to 
‘missing KIR ligand’ model, which has been used to predict KIR-mediated NK 
alloreactivity and outcome of allogeneic HCT (Leung et al., 2004). 
 
1.7 Genetic Susceptibility in Nasopharyngeal Carcinoma  
1.7.1 Nasopharyngeal Carcinoma 
Nasopharyngeal carcinoma (NPC), a relatively rare disease in other parts of the 
world, occurs with high incidence in China and ethnic Chinese in South East Asia, 
including Singapore Chinese.  Chinese incidence rates of 25-50 per 100 000 is high 
compare with Caucasian rates of less than one per 100 000 (Chan, 1990).  Other 
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populations with increased risk of NPC include non-Chinese Mongoloid groups 
(Muir, 1971), African (Hall et al., 1982; Herait et al., 1983), Pacific Island Polynesian 
(Morton and Benjamin, 1989) and other natives of the Artic region (Nutting et al., 
1993).  
 
1.7.2 HLA and NPC 
NPC development has been linked to the ubiquitous Epstein-Barr virus (EBV) as well 
as several host susceptibility factors, including HLA genes.  Previous reports have 
convincingly shown that HLA class I molecules are involved in adaptive immunity 
with NPC (Simons et al., 1974; Chan et al., 1983; Burt et al., 1994).  In adaptive 
immunity, human HLA class I molecules function by presenting specific foreign 
antigens to cytotoxic CD8+ T cells that subsequently recognize and lyse infected 
cells.  
 
In Singaporean populations, HLA genes have been extensively studied and ample 
evidence had supported that HLA gene as significant risk factors for NPC (Simon et 
al., 1974; Chan et al., 1983).  In particular, several HLA class I alleles, including 
HLA-A0207, A3303, B5801 and B4601 are linked to increased risk of NPC while 
A1101 and B1301 have been protective against NPC.  Singapore Chinese have an 
increased incidence compared to other ethnic groups in Singapore such as Malay and 
Indian (incidence rate of NPC per 100 000 per year is 18.5, 3.1 and 0.9 respectively), 
though they live together and share many eating and social habits (Shamugaratnam 
and Wee, 1973).  This indicates that genetic susceptibility plays a more important role 
than social or environmental factors in NPC pathogenesis.  
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1.7.3 Innate Immunity and NPC 
There is emerging evidence that the innate arm of the immune system mediates and 
regulates tumor immunity.  NK cells provide defense in the early stage of the innate 
immune response by producing cytokines and causing cytotoxicity.  HLA molecules 
are also involved in innate immunity, which is rapidly activated in the early stage of 
an infection.  During virus infection, HLA molecules function as the ligands for NK 
cell receptors, mainly the activating KIRs, by directing non-specific cytotoxicity 
against virus-infected cells. Few studies had described risk of tumor in the context of 
innate immunity.  Carrington et al. (2005) and Kovacic et al. (2005) had investigated 
the association of innate immunity with pathogenesis of virus-induced cancers. 
Carrington et al. (2005) found that activating KIR3DS1, particularly in the absence of 
certain inhibitory KIR-ligand pairs, was associated with increased risk of cervical 
intraepithelial neoplasia and cervical cancer.  
 
Kovacic et al. (2005) had conducted a case-control study in Taiwanese (295 NPC 
cases and 252 community controls) to investigate whether innate immunity is 
associated with NPC.  They had demonstrated that increasing number of activating 
KIRs but not inhibitory KIRs might be associated with NPC risk, particularly in EBV-
positive carriers.  In addition, they described that specific combination of HLA-
B*4601 with its presumed ligand KIR2DS2 had shown increased risk of NPC, notably 
in EBV-seropositive individuals.  They had also investigated the effects of HLA-C 
genes on NPC risk and found that both HLA-Cw*0302 allele had increased risk of 




1.8 Aims of This Study 
KIR gene frequencies and genotype profiles in many populations have been defined in 
several populations by other groups of investigators.  Frequencies vary significantly 
between different populations.  However, the frequencies of KIR genes in 
Singaporean populations have not been studied before.  The aims of this study are: 
i) To determine the frequencies of KIR genes and pseudogenes in Singapore 
Chinese, Malay and Indian;  
ii) To compare KIR gene frequencies and genotype profiles in our 
populations with those previously described in other populations in the 
world; 
iii) To study KIR haplotype distribution in Singapore Chinese families; and 
iv) To evaluate the associations of KIR genes with NPC. 
 
NPC was chosen as the disease of interest for this study due to two reasons.  Firstly, 
the HLA genes had been found to be associated with NPC in the Singapore 
populations.  Being the NK receptors of HLA molecules, this association could be due 
to manifestion by the KIR genes or KIR in combination with HLA genes.  Secondly, 
there had been reports on the involvement of innate immunity in virus-causing 
cancers such as cervical cancer (Carrington et al., 2005) and NPC (Kovacic et al., 
2005).  Results of this study would be useful in our understanding of NPC and the 






































CHAPTER 2. MATERIALS AND METHODS 
 
 
2.1 Buffer, Solutions and Chemicals 
The media, buffer, solutions and reagents used in this study are listed in Appendix I. 
 
2.2 Study Samples 
DNA samples used in this study were obtained from total donor blood.  Samples for 
frequency studies consisted of a total of 370 individuals including 210 unrelated 
Singapore Chinese, 80 each of unrelated Singapore Malays and Singapore Indians. 
Blood samples were taken from healthy volunteers (for research and for the Bone 
Marrow Program and laboratory staff) after informed consent.  An additional six 
control DNAs from cell lines of the 10th International Histocompatibility Workshop 
(BH, E4181324, HOR, MZ070782, RML and TEM) were used for validation of 
specificity of the typing system used in this study.  These reference DNAs were 
included into each PCR set as postitive control.  Negative controls were PCR mix 
without DNA sample. 
 
Samples for haplotype studies consisted of 40 individuals from 11 unrelated 
Singapore Chinese families including patients and their family members of the 
BMDP, donors for research, or laboratory staff and their families.  For case-control 
studies, a total of 122 unrelated patients diagnosed with NPC and another 210 healthy 
individuals were typed for the presence and absence of KIR genes.  Both patient and 




2.3 Culture of B-Lymphoblastoid Cell Lines 
Epstein-Barr virus-transformed B-lymphoblastoid cell lines (BLCL) from donor 
samples were obtained previously from various sources and stored frozen in liquid 
nitrogen at the W.H.O. Collaborating Centre for Immunology, Singapore. 
 
2.3.1 Growth of BLCL 
BLCLs stored frozen in liquid nitrogen were thawed at 37 °C in a water bath and 
resuspended in 10 ml of RPMI (see Appendix I) under sterile condition.  Cells were 
pelleted by centrifugation at 1500 r.p.m. for 5 minutes.  Cell pellet was gently 
resuspended in 5 ml of tissue culture medium R10 medium (see Appendix I) and 
transferred to a 25-ml culture flask.  The cell culture was incubated at 37 °C in a 5% 
CO2 incubator.  The density of the cells was monitored and culture medium was 
added when necessary.  When the volume exceeded 15 ml, 80% of the cell culture 
was transferred to a 75-ml culture flask and 20 ml of fresh R10 medium was added. 
Five micro liter of fresh R10 medium was added to the remaining cell suspension in 
the 25-ml flask.  The resulting cell cultures were then incubated at 37 °C until ready 
for freezing and harvesting.  
 
2.3.2 Freezing BLCLs 
Upon achieving 80% confluent growth, cell culture in the 25-ml flask was centrifuged 
at 1500 r.p.m. for 5 minutes and the supernatant discarded.  The pellet was suspended 
in 1.5-ml ice-cold freezing mixture (see Appendix I) and transferred to a labeled vial. 
This vial was kept at -70 °C for a minimum of 2 hours and maximum of one day 
before being stored at -196 °C in liquid nitrogen locators.  
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2.3.3 Harvesting BLCLs 
Upon achieving confluent growth, cell culture in the 75-ml flask was centrifuged at 
2000 r.p.m. for 5 minutes and the supernatant discarded.  The cell pellet was then 
washed in 1 ml PBS (see Appendix I) and centrifuged at 1200 r.p.m. for 3~4 minutes, 
with the supernatant once again discarded.  Cell pellets were kept in eppendorf tube at 
-20 °C for short-term storage.  
 
2.4 Preparation of Genomic DNA from Cell Pellet 
 
2.4.1 DNA Extraction 
 
Genomic DNA was extracted from BLCL tissue culture cells using a commercial 
DNA extraction kit (Qiagen, Valencia, CA) according to the manufacturer’s 
instructions. 
 
2.4.2 Quantification of DNA 
The concentration of the extracted DNA in elution buffer of EB (10 mM Tris Cl, pH 
8.5) was estimated by spectrophotometry using GeneQuant Pro DNA/RNA 
Calculator (Amersham Pharmasia Biotech, Uppsala, Sweden).  dH2O was used to 
dilute samples and to calibrate the spectrophotometer.  Seven micro liters of DNA 
samples was diluted 10 fold with dH2O to a total of 70 µl in a microcentrifuge tube. 
The mixture was loaded to a 1-ml quartz cuvette and absorbance was taken for both 
wavelengths of 260 nm and 280 nm.  DNA concentration was calculated by 
multiplying the absorbance reading at 260 nm by 50 µg/ml and by dilution factor of 
10.  The purity of DNA samples was determined by the ratio of absorbance reading at 
260 nm to 280 nm with a desired ratio of 1.8~2.0.  Measurement was repeated twice 
for each DNA sample and the average value was taken.  
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2.5 Polymerase Chain Reaction-Sequence Specific Priming (PCR-SSP) Typing 
 
2.5.1 Primer Selection for PCR 
Genomic DNAs were typed for the presence of KIR genes 2DL1, 2DL2, 2DL3, 2DL4, 
2DL5, 2DS1, 2DS2, 2DS3, 2DS4, 2DS5, 3DL1, 3DL2, 3DL3, 3DS1, KIR1D and 
pseudogenes 2DP1 and 3DP1 by 17 PCR-SSP reactions per individual.  Each reaction 
contained one forward primer and one reverse primer specific for a single KIR gene or 
pseudogene.  DNA primer sequences were adapted from Uhrberg et al. (1997) and 
Hsu et al. (2002b).  The sequences of PCR-sequence-specific primers for the 
detection of each KIR gene or pseudogene in genomic DNA are shown in Table 2. 
Primers were purchased from commercial companies Research Instruments 
(Singapore) and Proligo (Singapore).  Primers were diluted in ddH2O to give a final 
concentration of 100 µM. Primer stock was subsequently diluted to be used in PCR 
amplifications.  
 
2.5.2 Validation of Typing System 
To confirm the specificity of the primers and to validate the typing system, PCR-SSP 
was performed on six control DNAs.  Results obtained on control DNAs were 
compared with results provided by another group (Gomez-Lozano and Vilches 2002). 
The specificity of the primers was confirmed by Basic Local Alignment Sequence 
Tool (BLAST) searches (http://www.ncbi.nlm.nih.gov/BLAST).  The amplification 
products were validated by sequencing and subsequently verified by BLAST.  PCR 




Table 2 Forward and reverse primers for identification of 17 KIR genes and pseudogenes 
 
Product size KIR Forward primer (5'-3') Reverse primer (5'-3') 
(base pairs) 
2DL1 CTGTTACTCACTCCCCCTATCAGG* AGGGCCCAGAGGAAAGTCA** 1770 
2DL2 CATGATGGGGTCTCCAAA** CCCTGCAGAGAACCTACA** 1808 
2DL3 CCTTCATCGCTGGTGCTG** CAGGAGACAACTTTGGATCA** 812 
2DL4 CCCCTCAACAGATACCAGCGTGTG* GCAGGCAGTGGGGACCTTAGACA* 271 
2DL5 GCTCTTCTTTCTCCTTCATTGCTGC* GCAGGCAGTGGGGACCTTAGACA* 1025 
2DS1 TCTCCATCAGTCGCATGAA** AGGGCCCAGAGGAAAGTT** 1838 
2DS2 CTTCTGCACAGAGAGGGGAAGTA** CACGCTCTCTCCTGCCAA** 1761 
2DS3 GACATGTACCATCTATCCAC** GCATCTGTAGGTTCCTCCT** 130 
2DS4 CTGGCCCTCCCAGGTCA** GGAATGTTCCGTTGATGC** ~2000 
2DS5 CTGCACAGAGAGGGGACGTTTAACC* TCCAGAGGGTCACTGGGC* 179 
3DL1 AAGACACCCCCTACAGATACCATCT* GCAGGCAGTGGGGACCTTAGACA* 277 
3DL2 CGGTCCCTTGATGCCTGT** GACCACACGCAGGGCAG** 1905 
3DL3 AACACGGAACTTCCAAATGCTGAGCG* GCAGGCAGTGGGGACCTTAGACA* 243 
3DS1 CAGCGCTGTGGTGCCTCGC* CTGTGACCATGATCACCAT* 249 
3DP1 ATCCTGTGCGCTGCTGAGCTGAG* GCCTATGAAAACGGTGTTTCGGAATAC* 344 
2DP1 GCAAGACACCCCCAACAGATACCAGA* GCAGGCAGTGGGGACCTTAGACA* 278 
1D ATCCTGCAATGTTGGTCG* CTGGATAGATGGAGCTGCAG* 1885 
    
Reference * Hsu et al. (2002) J Immunol 169:5118-5129   
                 ** Uhrberg et al. (1997) Immunity 7:753-763   
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2.5.3 PCR Profiles 
All PCR reactions were performed in 30-µl volume reaction containing 3 µl of 10x 
PCR buffer (Roche Diagnostics GmbH, Mannheim, Germany), 0.2 mM of 
deoxynucleoside triphosphate (dATP, dCTP, dGTP, dTTP) (Promega, Madison, WI), 
0.3 µM each of forward and reverse KIR-specific primers, 0.05-0.1 µg of template 
DNA and 2.5 U of Taq polymerase (Roche Diagnostics).  PCR protocol included an 
initial denaturation at 95 °C for 5 min, then 5 cycles of 97 °C for 30 sec, 62 °C for 45 
sec and 72 °C for 90 sec. This is followed by 30 cycles of 95 °C for 30 sec, 60 °C for 
45 sec and 72 °C for 90 sec.  All amplifications were performed in one of three 
thermal cyclers including GeneAmp PCR System 9700 (Perkin-Elmer, Norwalk, CT), 
GeneAmp PCR System 2400 (Perkin Elmer) and PTC-200 (MJ Research Inc., 
Watertown, MA).  
 
Annealing temperatures were modified for primers amplifying KIR2DL1 57°C/ 55°C; 
2DL2 54°C/ 52°C; 2DS1 53°C/ 51°C; 2DS2 58°C/ 56°C; 2DS3 53°C/ 51°C; 2DS4 
53°C/ 51°C; 3DL2 56°C/ 54°C; and KIR1D 54°C/ 52°C.  Extension time was 
modified for amplification of KIR2DS3 (1 min) and long-range amplification of 
KIR2DL1, 2DL2, 2DS1, 2DS2, 2DS4 and 3DL2 (2 min).  Number of amplification 
cycles was modified for KIR2DS1 (40 cycles) and 2DS4 (40 cycles). 
 
2.5.4 Agarose Gel Electrophoresis 
Electrophoresis of agarose gel was performed using the submerged horizontal gel 
system.  1.5% gel was used for analysis of DNA fragment in this study. Agarose was 
dissolved in 1x TBE buffer to an appropriate concentration.  Ethidium bromide 
solution (Bio-Rad, Hercules, CA) was added to a concentration of 0.5 µg/ml before 
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the gel was poured onto a casting tray.  10 µl of PCR amplification products were 
mixed with 5 µl of Ficoll loading buffer and then the mixture was loaded into the 
wells of the gel. 1-kb and 100-bp DNA ladders (Promega) were used as the molecular 
weight markers.  Electrophoresis was carried out at a constant voltage of 120 V in 1x 
TBE buffer for about 30-50 minutes.  DNA samples were then visualized under 
ultraviolet (UV) illumination with an UV illuminator and photographed on a camera. 
Positive gene-specific amplifications were identified by the presence of PCR gene-
specific amplicons of the correct size, whereas absence of gene-specific amplicons 
implied the absence of the genes identified in a given primer mix. 
 
2.6 Sequencing of PCR Amplification Products 
PCR products of each KIR gene and pseudogene were directly sequenced and 
subjected to Basic Local Alignment Search Tool (BLAST) in order to validate the 
primers and to confirm the amplification products.  Nucleotide sequencing of 
amplification products was performed using dye terminators and automated 
sequencing. 
 
2.6.1 Preparation of DNA Template 
Because sequencing requires a relatively large amount of DNA, PCR is used to 
amplify DNA samples.  A 30-µl volume of PCR reaction was performed under 
optimized conditions. Five micro liters of the reaction mixture was checked for a 
single, discrete band by agarose gel electrophoresis.  The remaining PCR product was 
subjected to gel electrophoresis, the DNA fragments of expected size was cut out and 
weighed.  Gel extraction was performed whereby DNA fragments were purified using 
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the Qiagen Gel Extraction Kit (Qiagen, Hilden, Germany) according the 
manufacturer’s instruction.  
 
2.6.2 Preparation of Sequencing Reactions 
The ABI prism Big DyeTM Terminator Cycle Sequencing Ready Kit (Perkin Elmer 
Applied Biosystems Division, Foster City, CA) was used for DNA sequencing.   Two 
separate tubes for each sample were prepared, one with the forward primer and the 
other with the reverse primer.  10-µl of reaction mixture which contained 5 µl of big 
dye, 2 µl of sequencing buffer, 1 µM of primer (forward or reverse), 100 ng of DNA 
as the template and sterile ddH2O was prepared and mixed well, spun down briefly 
and placed in the GeneAmp PCR System 9700 (Perkin Elmer, CT) thermal cycler 
under the following condition: One cycle of 96 °C for 1 min followed by 25 cycles of 
96 °C for 10 sec, 50 °C for 5 sec and 60 °C for 4 min.  The amplified products were 
then kept at 4 °C until purification. 
 
2.6.3 Purification of Extension Products and DNA Sequencing 
The extension products were purified using the ethanol/sodium acetate precipitation 
procedure to remove excess dye terminators.  For each sequencing reaction, a 1.5-ml 
centrifuge tube containing 1 µl of 3 M sodium acetate (pH 4.6) and 25 µl of absolute 
ethanol was prepared.  The entire contents of each extension reaction was transferred 
into the tube and mixed thoroughly by vortexing.  The tubes were then incubated at -
20 °C for 20 minutes to precipitate the extension products.  Then, the tubes were 
centrifuged at 13200 r.p.m. for 15 minutes.  The supernatant was carefully aspirated 
with the use of a pipette and discarded.  The pellet was rinse with 200 µl of 75% 
ethanol and centrifuged at 13200 r.p.m. for 15 minutes.  Again, the supernatant was 
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aspirated and discarded.  The pellet was then dried at 70 °C for 4 minutes.  Each dried 
sample pellet was resuspended in 15 µl of Hi-DiTM Formamide (Applied Biosystems, 
CA).  Sequencing was subsequently performed by capillary electrophoresis on the 
ABI PRISM 3100-Avant Genetic Analyzer (Applied Biosystems). 
 
2.7 Statistical Analysis 
Observed gene frequencies were determined from the number of positive typing 
reactions divided by the total number of individual typed.  Estimated gene frequencies 
or KIR locus frequencies (KLFs) were calculated by the formula KLF=1- )1( f− , 
where f is the observed frequency in a population.  The difference in KIR genes 
frequencies among the three ethnic groups and the association between KIR genes, 
HLA alleles, or combination of KIR genes and HLA alleles with NPC was assessed by 
the standard chi-square test (χ2) and contingency tables.  If direct counting is less than 
five, Fisher exact test was applied.  The probability (P) values were used to scale the 
level of significance.  P values of less than 0.05 were considered significant.  To 
correct for chance finding of significant difference among ethnic groups, the P values 
was multiplied by the number of total KIR sequences tested (n=17), to give the 
corrected P (Pc) values.  The magnitude of effect was estimated by odds ratio (OR) 
values and their 95% confidence intervals (CI). 
 
Linkage disequilibrium (LD) between pairs of KIR genes/loci was estimated by 
linkage disequilibrium value (D) and relative LD values (r).  D values and r values 
were computed by using the 2BY2 program in the Linkage Utility program written by 
Jurg Ott (http://linkage.rockefeller.edu/ott/linkutil.htm#2BY2) (Ott, 1999).  D was 
give by: P (i,j) – [P(i)*P(j)], where P (i, j) is the frequency of the two loci occurring 
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together and P(i) and P(j) are the gene frequencies of the two loci.  The significance 
of LD values was assessed by two-tailed Fisher’s exact test using 2x2 contingency 
tables. 
 
2.8 KIR Haplotype Analysis 
KIR haplotypes were resolved from genotypes based on haplotype models described 
by Hsu et al. (2002b).  KIR haplotypes were determined by segregation analysis in 
families, based on assumptions that framework genes are always present and alleles of 
the same locus do not appear together on one haplotype, as the following: 1). All 
haplotypes contained the ubiquitous KIR3DL3, 3DP1, 2DL4 and 3DL2. 2). 
Haplotypes contained either KIR2DL2 or 2DL3, but not both. 3). Haplotypes 
contained either KIR3DL1 or 3DS1, but not both. 4). Haplotypes contained either 





























































CHAPTER 3. RESULTS 
 
3.1 Validation of PCR-SSP Typing 
Confirmation of specificity of primer sets and validation of typing method were 
accomplished in several ways.  Six control DNAs from cell lines of the 10th 
International Histocompatibility Workshop were typed using the same primer sets and 
PCR-SSP typing method, with 100% concordant results (data not shown).  For quality 
control of the typing system, these six DNA samples were included in each typing as 
positive and negative controls.  The presence or absence of KIR amplified products 
was analyzed on 1.5% agarose gel.  Fig 3.1 shows a gel picture of all 17 KIR 
fragments with correct band size.  The PCR amplification products were sequenced 
for specificity and subsequently verified through alignment with sequences that were 
found as matches in the database using the BLAST provided online by the National 
Center for Biotechnology Information (see Appendix II).  
 
Typing for a KIR2DS4 gene variant, namely KIR1D was included in this study, using 
a primer set different from that for 2DS4.  KIR1D is characterized by a 22-bp deletion 
in the second extra-cellular Ig-like domain.  Although the reminder of the nucleotide 
sequence is identical to 2DS4, this deletion generated a frame shift and resulting in a 
novel amino acid sequence distinct from 2DS4, without the cytoplasmic domain. 
These (2DS4 and KIR1D) could be identified as two different amplicons, whose sizes 












      
 
 
Fig 3.1 Analysis of PCR amplification products of 17 KIR genes and pseudogenes 
on 1.5% agarose gel. 1-kb and 100-bp DNA ladders (Promega) as molecular weight 



































































































    500  
  1000  
  1500  
  2000  
    300  
    100  
    200  
   bp 
  41
3.2 KIR Gene Frequencies 
 
The observed KIR gene frequency was determined by the ratio of gene present within 
a population to the total population number.  The percentage of individuals possessing 
each of 17 KIR genes and pseudogenes in Singapore Chinese, Malay and Indian 
populations are illustrated in Fig 3.2.  All 17 KIR sequences tested for were detected 
in all three Singaporean populations.  The framework genes and pseudogenes 
KIR3DL3, 3DP1, 2DL4 and 3DL2 as well as the non-framework pseudogene 2DP1 
were present in 100% of three Singaporean ethnic groups.  Other KIR genes were 
present in distinct subsets of Singaporean populations.  
 
Each ethnic group had a distinct pattern of KIR distributions as expected, since they 
are from distinct origins.  In general, higher gene frequencies were observed in 
Singapore Indian compared with Singapore Chinese and Singapore Malay for genes 
characteristic of B haplotypes including KIR2DS2, 2DL2, 3DS1, 2DL5, 2DS3, 2DS5 
and 2DS1, as well as a gene characteristic of A haplotypes, namely KIR1D.  
 
Among the non-ubiquitous genes, KIR2DS2, 2DL2, 2DL5 and 2DS5 exhibited 
greatest variability among the three ethnic groups, particularly between Singapore 
Chinese and Singapore Indian.   The significant difference in percentage observed for 
KIR2DS2, 2DL2, 2DL5 and 2DS5 between these two ethnic groups were 41.9%, 
48.3%, 40.2% and 39.8% respectively.  
 
Data also showed that, among the 17 KIRs, KIR2DS3 and 2DS5 were found to occur 



















Fig 3.2 Frequencies of 17 KIR genes tested for in three Singaporean populations. Genes are arranged according to the genomic 
organization of KIR cluster on the chromosome. Black bars designate Singapore Chinese, hatched bars designate Singapore Malay and white 
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was present in only 15.2% of Singapore Chinese and 27.5% of Singapore Malay.   
The gene that occurred with the lowest frequency in Singapore Indian was KIR2DS3 
(40%). 
3.3 KIR Locus Frequencies (KLFs) 
The observed KIR frequencies along with the estimated gene frequencies (given by 
KLFs) of 17 KIR sequences in each of the three Singaporean populations are shown in 
Table 3.1.  Besides the five genes and pseudogenes, namely KIR3DL3, 2DP1, 3DP1, 
2DL4 and 3DL2, that were positive in all samples tested (KLF =1.00), all 12 other 
genes had estimated KIR locus frequencies (KLFs) that vary across the three 
populations.  The difference in frequencies amongst the three populations was 
assessed with χ2 test and only significant values were provided. 
 
Seven KIRs were found to occur with significant difference in frequencies among the 
three Singaporean populations.  Four out of these seven genes, including KIR2DS2, 
2DL2, 2DL5 and 2DS5 had frequencies with greatest significant variation (Pc <0.002) 
in different populations.  Six out of these seven genes occurred most frequently in 
Singapore Indian, followed by Singapore Malay and Singapore Chinese, namely 
KIR2DS2 (KLF 0.09-0.37), 2DL2 (KLF 0.11-0.44), 2DL5 (KLF 0.22-0.54), 2DS3 
(KLF 0.11-0.23), 2DS5 (KLF 0.08-0.33) and KIR1D (KLF 0.24-0.41).  In contrast, 
KIR2DL1 occurred with the lowest frequency in Singapore Indian, followed by 









Table 3.1 Observed KIR frequencies and estimated gene frequencies (KLFs) in three Singaporean populations 
 
 
    KIR genes 
  3DL3 2DS2 2DL2 2DL3 2DP1 2DL1 3DP1 2DL4 3DL1 3DS1 2DL5 2DS3 2DS5 2DS1 2DS4 1D 3DL2 
Chinese f      (observed frequency) 1.00 0.18 0.21 0.90 1.00 0.96 1.00 1.00 0.96 0.38 0.39 0.20 0.15 0.34 0.89 0.42 1.00 
(n=210) KLF (estimated frequency) 1.00 0.09 0.11 0.68 1.00 0.80 1.00 1.00 0.80 0.21 0.22 0.11 0.08 0.19 0.67 0.24 1.00 
Malay f      (observed frequency) 1.00 0.31 0.43 0.91 1.00 0.90 1.00 1.00 0.91 0.35 0.56 0.31 0.28 0.36 0.95 0.49 1.00 
(n=80) KLF (estimated frequency) 1.00 0.17 0.24 0.70 1.00 0.68 1.00 1.00 0.70 0.19 0.34 0.17 0.15 0.20 0.78 0.28 1.00 
Indian f      (observed frequency) 1.00 0.60 0.69 0.85 1.00 0.81 1.00 1.00 0.91 0.50 0.79 0.40 0.55 0.54 0.76 0.65 1.00 
(n=80) KLF (estimated frequency) 1.00 0.37 0.44 0.61 1.00 0.57 1.00 1.00 0.70 0.29 0.54 0.23 0.33 0.32 0.51 0.41 1.00 
χ2 (2x3)   48.52 60.90   17.20     38.52 13.66 47.09   12.38  
Pc    <0.002 <0.002   0.003     <0.002 0.019 <0.002   0.036  
 
χ2 is calculated from 2x3 contingency table using observed frequencies. Pc is P values corrected by multiplying with the number of KIR tested (n=17). Only significant χ2 






Estimated gene frequencies showed that KIR2DS5 was the least frequent locus in 
Singapore Chinese (KLF =0.08) as well as in Singapore Malay (KLF =0.15), and 
KIR2DS3 being the least frequent in Singapore Indian, with KLF of 0.23.  
 
3.4 Linkage Disequilibrium (LD) 
LD analysis is a statistical method used to the study of association of KIR alleles of 
two or more loci.  The degree of LD measures the association between KIR genes at 
different loci.  Disequilibrium values (D), relative linkage disequilibrium values (r) 
and significant P values observed for KIR pairs are illustrated in Table 3.2.  The five 
genes and pseudogenes observed with 100% frequencies in Singaporean populations 
were excluded from LD analysis.  This analysis revealed some significant positive 
and negative associations across the three populations.  Significant associations 
between pairs of KIRs are highlighted in Table 3.2.  
 
Data showed that genes KIR2DS2, 2DL2, 2DL5 and 2DS3 were in positive linkage 
with one another in all three Singaporean populations.  All three genes KIR3DS1, 
2DS5 and 2DS1 were also strongly associated with one another and each of them was 
in significant LD with 2DL5 in all three Singaporean populations.  All these genes are 
the constituents of the B haplotypes, thus not surprising that they were in positive 
linkage.  Positive LD between KIR2DL1 and 2DL3 was also observed in all 
populations, consistent with associations between constituents of A haplotypes.  
 
B haplotype gene KIR2DS1 was found in strong negative association with A 
haplotype gene KIR1D in all three populations, supporting the assumption that these 
two genes never occurred on the same haplotype.  Significant negative linkage was
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Table 3.2 Linkage disequilibrium for pairs of KIR genes in three Singaporean populations 
    2DL2   2DL3  2DL1  3DL1  3DS1 
   C M I   C M I  C M I  C M I  C M I 
2DS2 D 0.130 0.167 0.138  -0.014 -0.048 -0.048 -0.007 -0.056 -0.038 -0.007 -0.023 -0.010 0.032 0.041 0.013
  r 0.901 0.930 0.733  0.168 0.792 0.792 0.237 0.818 0.500 0.186 0.377 0.286 0.283 0.200 0.063
  P 0 0 0  0.0853 0.0032 0.0225 0.1591 0.0009 0.1419 0.2094 0.1964 0.6962 0.0163 0.1308 0.8197
2DL2 D    -0.012 -0.038 -0.047 -0.011 -0.058 -0.046 -0.006 -0.025 -0.015 0.033 0.039 -0.006
  r    0.143 0.752 1 0.371 1 0.787 0.162 0.503 0.543 0.254 0.193 0.040
  P    0.1694 0.0380 0.0144 0.0571 0.0006 0.0291 0.3936 0.1287 0.4245 0.0214 0.1614 1
2DL3 D    0.010 0.066 0.097 -0.005 0.017 0.024 0.001 -0.032 0.013
  r    0.302 0.841 0.795 1 0.217 0.328 0.033 0.560 0.167
  P    0.0397 0 0 0.6020 0.1120 0.0648 1 0.0476 0.7555
2DL1 D    -0.002 0.016 0.021 0.005 -0.040 0.019
  r    1 0.206 0.297 0.335 0.615 0.200
  P    1 0.1428 0.1178 0.7129 0.0195 0.5679
3DL1 D     -0.017 -0.019 -0.044
  r     0.644 0.341 1
  P     0.0282 0.2321 0.0117
3DS1 D     
  r     
  P     
2DL5 D     
  r     
  P     
2DS3 D     
  r     
  P     
2DS5 D     
  r     
  P     
2DS1 D     
  r     
  P     
2DS4 D     
  r     
  P                        
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    2DL5   2DS3  2DS5  2DS1  2DS4  1D 
  C M I   C M I  C M I  C M I  C M I  C M I 
2DS2 D 0.073 0.087 0.065  0.046 0.102 0.073 0.015 0.027 0.008 0.039 0.037 0.003 -0.017 -0.022 0.010  -0.019 0.010 -0.003 
 r 0.657 0.634 0.510  0.313 0.476 0.453 0.123 0.141 0.034 0.324 0.184 0.012 0.186 0.636 0.074  0.246 0.063 0.018 
 P 0 0.0007 0.0053  0.0001 0 0.0101 0.1335 0.2867 0.8216 0.0040 0.2092 1 0.0498 0.0880 0.7859  0.2034 0.8104 1 
2DL2 D 0.078 0.086 0.046  0.046 0.105 0.088 0.016 0.021 -0.003 0.040 0.021 0.018 -0.015 -0.016 0.023  -0.029 0.018 -0.009 
 r 0.621 0.462 0.316  0.295 0.583 0.700 0.136 0.130 0.022 0.297 0.101 0.107 0.162 0.565 0.192  0.334 0.082 0.086 
 P 0 0.0028 0.0405  0.0001 0.0001 0.0005 0.1505 0.4538 1 0.0035 0.4853 0.6292 0.1096 0.3065 0.2472  0.0392 0.6514 0.8030 
2DL3 D 0.002 -0.026 -0.032  -0.003 -0.035 -0.078 0.002 -0.001 -0.018 -0.003 -0.043 -0.007 0.002 0.033 0.041  0.006 0.005 0.023 
 r 0.057 0.674 1  0.040 0.584 0.861 0.105 0.015 0.295 0.039 0.776 0.099 0.025 0.726 0.355  0.132 0.121 0.231 
 P 1 0.1291 0.0608  0.7759 0.0281 0.0001 1 1 0.5320 0.8141 0.0081 0.7648 0.7234 0.0016 0.0228  0.6526 1 0.3260 
2DL1 D -0.009 -0.044 -0.002  -0.002 -0.056 -0.050 -0.004 -0.010 -0.009 -0.006 -0.051 0.013 0.005 0.033 0.033  0.006 0.011 0.034 
 r 0.390 1 0.059  0.068 0.818 0.444 0.115 0.138 0.111 0.245 0.804 0.132 0.153 0.722 0.226  0.403 0.231 0.282 
 P 0.2652 0.0082 1  0.6554 0.0009 0.0380 0.3508 0.6775 0.7770 0.4474 0.0029 0.5775 0.2287 0.0026 0.0907  0.4726 0.7127 0.1343 
3DL1 D -0.017 -0.038 -0.006  -0.011 -0.035 -0.015 -0.013 -0.038 -0.039 -0.019 -0.056 -0.041 0.024 0.021 0.043  0.013 0.043 0.057 
 r 0.638 1 0.328  0.310 0.584 0.286 0.345 0.606 1 0.664 1 1 0.624 0.452 0.631  0.735 1 1 
 P 0.0291 0.0164 1  0.0750 0.0281 0.4288 0.0324 0.0151 0.0147 0.0078 0.0005 0.0134 0.0001 0.0365 0.0055  0.0827 0.0119 0.0004 
3DS1 D 0.145 0.103 0.069  0.065 0.066 0 0.081 0.079 0.113 0.159 0.111 0.106 -0.024 -0.020 -0.025  -0.048 -0.033 -0.025 
 r 0.629 0.674 0.647  0.521 0.323 0 0.850 0.441 0.500 0.752 0.496 0.460 0.332 0.615 0.222  0.305 0.194 0.143 
 P 0 0.0001 0.0052  0 0.0115 1 0 0.0015 0.0001 0 0 0.0003 0.0419 0.1207 0.4225  0.0039 0.2472 0.482 
2DL5 D    0.120 0.137 0.073 0.075 0.120 0.104 0.193 0.159 0.102 -0.037 -0.009 -0.010  -0.057 0.001 -0.0119 
 r    1 1 0.853 0.797 1 0.893 0.931 1 0.891 0.525 0.429 0.215  0.352 0.004 0.160 
 P    0 0 0.0015 0 0 0 0 0 0 0.0013 0.6276 0.7495  0.0009 1 0.776 
2DS3 D    -0.011 0.002 -0.008 0.077 0.049 0.023 -0.025 -0.009 0.015  -0.034 0.010 0.0400 
 r    0.360 0.008 0.034 0.595 0.247 0.122 0.275 0.273 0.167  0.418 0.063 0.286 
 P    0.3401 1 0.8216 0 0.0778 0.4946 0.0106 0.5853 0.5922  0.0132 0.8104 0.155 
2DS5 D    0.091 0.163 0.167 -0.006 0.001 -0.051  -0.026 -0.034 -0.0700 
 r    0.906 0.929 0.670 0.066 0.091 0.506  0.403 0.254 0.444 
 P    0 0 0 0.3789 1 0.0332  0.0505 0.2144 0.010 
2DS1 D     -0.038 -0.019 -0.004  -0.051 -0.077 -0.0744 
 r     0.496 0.608 0.039  0.361 0.434 0.460 
 P     0.0009 0.1328 1  0.0018 0.0054 0.0091 
2DS4 D      -0.009 0.024 0.021 
 r      0.139 1 0.145 





C indicates Singapore Chinese, M indicates Singapore Malay and I indicates Singapore Indian. D is linkage disequilibrium value; r is relative linkage disequilibrium. Pairs with significant 
values <0.05 are highlighted.  
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also observed between A haplotype gene KIR3DL1 with B haplotype genes KIR2DS5 
and 2DS1 respectively in all three populations.  These results were consistent with 
negative associations between characteristic genes of two different haplotypes groups. 
In general, LD results confirmed that certain KIR sequences especially those 
belonging to the same haplotype group invariably occur together whereas others such 
as alleles of the same locus or genes characteristics of different haplotype groups 
donot appear together.  Besides the 16 LDs stated, other previously described LDs 
were also noted in only one or two, but not all three Singaporean populations.  For 
instance, significant LD of KIR2DS2 with 2DL3, 2DL2 with 2DL3, 2DL2 with 2DL1, 
2DL3 with 2DS3, 2DL1 with 2DS3, 2DL3 with 2DS4 and 3DL1 with KIR1D were 
present in Singapore Malay and Singapore Indian.  Positive LD of KIR3DL1 with 
2DL5 and 3DS1 with 2DS3 were present in Singapore Chinese and Singapore Malay 
while negative LD of 3DL1 and 3DS1 was observed in Singapore Chinese and 
Singapore Indian. 
 
3.5 Comparison of Gene Frequency 
Table 3.3 shows the comparison of KIR gene frequencies in Singapore Chinese, 
Malay and Indian with Chinese Han, Japanese, Korean, Shanghai Chinese, Thai, 
Palestinian, north Indian Hindus, Indian Asian, Afro-Caribbean, Caucasian, 
Vietnamese, and Australian Aborigine previously studied and reported by other 
groups (Uhrberg et al., 1997; Witt et al. 1999; Crum et al., 2000; Norman et al., 2001; 
Toneva et al., 2001; Hsu et al., 2002b; Rajalingam et al., 2002; Yawata et al., 2002a; 
Cook et al., 2003; Zhang et al., 2003; Jiang et al., 2005; Whang et al., 2005). 
KIR3DL3, 2DP1, 3DP1, 2DL4 and 3DL2 that were present in 100% of the 
Singaporean populations appeared in agreement with 100% frequencies in other  
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Table 3.3 KIR gene frequencies in percentage in Singapore Chinese, Malay and Indian as compared with frequencies reported for 
other populations. NT: not tested 
KIR genes  
3DL3 2DS2 2DL2 2DL3 2DP1 2DL1 3DP1 2DL4 3DL1 3DS1 2DL5 2DS3 2DS5 2DS1 2DS4 1D 3DL2 
 




































Sgp Malay (n=80) a 
 
100 31.3 42.5 91.3 100 90.0 100 100 91.3 35.0 56.3 31.3 27.5 36.3 95.0 48.8 100 
Sgp Indian (n=80) a 
 
100 60.0 68.8 85.0 100 81.3 100 100 91.3 50.0 78.8 40.0 55.0 53.8 77.5 65.0 100 
Chinese Han (n=104) b 
 
100 17.3 17.3 99.0 99.0 99.0 100 100 94.2 32.7 34.6 12.5 23.1 34.3 94.2 NT 100 
Japanese (n=41) c 
 
100 15.0 15.0 100 100 100 100 100 97.0 30.0 39.0 15.0 25.0 35.0 97.0 NT 100 
Korean (n=154) d 
 
100 16.9 14.3 99.4 100 99.4 100 100 94.2 36.4 38.3 16.2 26.6 37.7 94.2 39.6 100 
Shanghai Chinese (n=87) e 
 
100 <10.0 <10.0 85.0 85.0 85.0 85.0 100 100 19.0 21.0 18.0 13.0 20.0 51.0 NT 100 
Thai (n=119) f 
 
NT 44.0 42.0 97.0 NT 97.0 NT 100 93.0 44.0 NT 25.0 23.0 42.0 87.0 NT 100 
Palestinian (n=105) f 
 
NT 64.0 62.0 85.0 NT 83.0 NT 100 88.0 39.0 NT 37.0 27.0 44.0 88.0 NT 100 
North Indian Hindus (n=72) g 
 
100 62.5 79.2 65.3 NT 87.5 NT 100 87.5 38.9 79.2 43.1 47.2 54.2 80.6 NT 100 
Indian Asian (n=35) h 
 
NT 57.0 54.0 86.0 NT 86.0 NT NT 91.0 40.0 26.0 29.0 51.0 49.0 83.0 NT NT 
Afro-Caribbean (n=54) h 
 
NT 52.0 54.0 91.0 NT 91.0 NT NT 98.0 17.0 33.0 24.0 30.0 17.0 78.0 NT NT 
Caucasian (n=465) i 
 
NT 51.8 44.0 92.7 NT 93.8 NT 100 94.0 41.9 52.0 26.5 33.6 47.7 35.5 78.8 100 
Vietnamese (n=59) j 
 
NT 42.0 36.0 98.0 NT 98.0 NT NT 87.0 42.0 NT 33.0 0 37.0 87.0 NT 100 
Aus. Aborigines (n=67) j  NT 85.0 79.0 67.0 NT 73.0 NT NT 55.0 78.0 NT 82.0 0 83.0 50.7 NT 100 
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a Present study 
b Jiang et al. (2005) Tissue Antigens 65:556-563 
c Yawata et al. (2002a) Immunogenetics 54:543-550 
d Whang et al. (2005) Hum Immunol 66:146-154 
e Zhang et al. (2003) Zhonghua Yi Xue Yi Chuan Xue Za Zhi 20(5):396-399 (Article in Chinese) 
f Norman et al. (2001) Immunogenetics 52:195-205 
g Rajalingam et al. (2002) Immunogenetics 53:1009-1019 
h Cook et al. (2003) Eur J Imunogenet 30:213-221 
I Cumulative gene frequencies from the previous studies by Uhrberg et al. (1997) Immunity 7:753-763; Witt et al. (1999) Transplantation 68:1784-1789; Crum et al. (2000) 
Tissue Antigens 56:313-326; Norman et al. (2001) Immunogenetics 52:195-205; Toneva et al. (2001) Tissue Antigens 57:358-362; and Hsu et al. (2002b) J Immunol 
169:5118-5129 for 2DS4 and KIR1D 
j Toneva et al. (2001) Tissue Antigens 57:358-362 
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populations tested, except 2DP1 and 3DP1 in Shanghai Chinese, which was only 85% 
frequent, and 2DP1 in Chinese Han, which was 99% positive.  Occurrence of other KIRs 
in Singaporean populations varied from other panels.  KIR2DS2 and 2DL2 in Singapore 
Chinese, Chinese Han, Japanese, Korean and Shanghai Chinese appeared in similarly 
low frequencies (<10-18.1% and <10-20.5% respectively) in contrast to the frequencies 
in other populations, which ranged from 31.3-85% and 36-79% respectively.  In general, 
great similarities in frequencies of most KIR genes tested were observed between 
Singapore Chinese and Chinese Han, Japanese, Korean and Shanghai Chinese.  
 
Singapore Indian had the highest frequency for KIR2DS5 (55%) gene compared among 
all populations, close to 47.2% frequency in north Indian Hindus and 51% frequency in 
Indian Asian.  For the most part, Singapore Indian had gene frequencies with great 
compatibilities to those of north Indian Hindus.  In addition, data also showed that 
Singapore Malay had gene frequencies comparable to those of Thai population, although 
several disparities were present, ranging from 0.5% for KIR2DL2 to 12.7% for 2DS2. 
 
Typing for KIR1D was performed in this study, which was not included in other 
populations except in Korean by Whang et al. (2005) and in Caucasian by Hsu et al. 
(2002b).  KIR1D is a variant of the activating gene KIR2DS4 that had a 22-bp deletion in 
exon 5 resulting in loss of transmembrane domain, presumably forming a soluble 
molecule.  KIR1D in Singaporean populations appeared with frequencies ranging from 
41.9-65%, higher than that of Korean (39.6%) but lower than that of Caucasian (78.8%).  
The full-length form of KIR2DS4 (77.5-95%) was the predominant subtype of 2DS4 in 
our population, similar to Korean (94.2% for 2DS4).  In contrast, KIR1D is the 
predominant subtype of 2DS4 in Caucasian (78.8% vs. 35.5%).  In general, data 
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demonstrated that Singaporean populations are distinct in KIR gene frequencies in 
comparison to other populations, with similarity to some Asian populations. 
 
3.6 KIR Profiles 
Fig 3.3 shows the KIR profiles in Singapore Chinese, Malay and Indian in comparison 
with those in other populations including Japanese (Yawata et al., 2002a), Chinese Han 
(Jiang et al., 2005), north Indian Hindus (Rajalingam et al., 2002), U.S.A. Caucasian 
(Hsu et al., 2002b), U.K. Caucasian (Norman et al., 2001), Australian Caucasian (Witt et 
al., 1999), Greek Caucasian (Niokou et al., 2003), Thai (Norman et al., 2001), 
Palestinian (Norman et al., 2001), Vietnamese (Toneva et al., 2001) and Australian 
Aborigine (Toneva et al., 2001).  
 
In total, 98 different KIR genotypes were found in 370 individuals from three 
Singaporean populations tested, 47 of which had been observed in other populations and 
51 of which had not been described in other populations and appeared unique to our 
populations.  Novel profiles (1-51) were present in approximately 25%, 33% and 28% in 
Singapore Chinese, Malay and Indian respectively.  Most of the novel profiles were 
unique to one of the three populations, only three of which were shared among two or 
more Singaporean populations.  Novel profiles were observed at low frequencies within 
a population, each one accounting for not more than 3.3% in Singapore Chinese and not 
more than 5% in Singapore Malay and Singapore Indian.  Among the novel profiles, 
profiles 10 corresponding to homozygous AA haplotypes and 40 corresponding to 
heterozygous AB haplotypes occurred with the highest frequencies (7.5%) in two and 

























































































































































AA1 AA +  + +     +  + + +  + +  19.1 16.3 2.5 56.0   5.6   30.2 27.2 24.5 35.3 22.9 42.4 1.5 
AA2 AB +  + + + +   +  + + + + + +  2.4 2.5          1.5 12.3 2.6 1.7 6.7 8.5 4.5 
AA2.1 AB +  + + + +   + + + + + + + +  5.2 3.8 5.0 19.5   2.8   8.8   4.3 4.2 1.9     
AA8 AB +  + + + +  + +  + + + + + +  5.2 2.5   7.3       0.7 0.7 3.4 4.2 1.0     
AA9 BB +  + + + +  +  +  + + + + +  1.0               0.7 0.4 0.8       
AA101 AB +  + + + +   +   + + + + +  0.5             0.7   0.4 0.8       
AA102 BB +  + + + +    +  + + + + +      1.3 2.4       1.5   0.9 1.7 1.9     
AB1 AB + + + +   +  +  + + +  + +  0.5     4.8   5.6   11.0 9.5 8.6 11.8 11.4     
AB3 AB + + + +  + +  +  + + + + + +  0.5             2.2 7.5 4.3 4.2 1.0     
AB4  AB + + + + + + + + +  + + + + + +    1.3       1.4   7.4 7.5 7.3 4.2 3.8 3.4 14.9 
AB4.1 AB + + + + + + + + + + + + + + + +  0.5             3.7   2.2 3.4 1.9     
AB5.1 AB + + + + + + +  + + + + +  + +    1.3 6.3     2.8   2.9   0.4 0.8 1.9     
AB8.1 AA + + + +     +  + + +  + +  1.4 2.5 1.3                       
AB9 AB + + + + +  + + +  + + +  + +  1.4 3.8   2.4   6.9   5.2 0.7 4.7 3.4 10.5 5.1 4.5 
AB10 AB + + + + +  + + +  + + + + + +  1.0             0.7 0.7 2.2 3.4       
AB103 AB + + + + + + +     + + + + +  0.5                0.4 1.7 2.9     
AB103.1 AB + + + + + + +   +  + + + + +  1.4   2.5     2.8                 
AB105 AB + + + + + +   + + + + + + + +      2.5                 1.0     
AB106 AB + + + + + + + + + +  + + + + +    2.5       1.4           1.0     
AB107 AB + + + + + + +    + + +  + +  0.5                           
BB2 AB  +  + + + + + +  + + + + + +    1.3          2.2 2.7 2.2 0.8 1.9     
BB2.1 AB  +  + + + + + + + + + + + + +  0.5         2.8         1.7 1.9     
BB4 AB  +  + + + +  + + + + + + + +  0.5             0.7 1.4     1.0     
BB7 BB  +  + + + + +    + + + + +    2.5 1.3           0.7 0.9   1.0   22.4 
BB8 AB  +  + + + + +   + + + + + +      1.3           0.7 1.3         
BB101 AB  +  + +  + + +  + + + + + +      1.3         1.5   0.9         
BB102 AB  +  + +  + + +  + + +  + +      1.3     1.4   1.5   3.9   5.7     
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BB104.1 BB  +  + + + +   +  + + + + +    1.3                         
C103 AB  + + + + + + + + + + + + + + +    1.3               0.4   1.0     
C105 AB + +  + +  + + +  + + +  + +  0.5                 2.2   1.0     
C106 AB   + + + + +  + + + + +  + +      1.3                       
C AB + + + + + + +   + + + + + + + +     1.3   1.9   1.2               
D AB + + + +   + + +  + + + + + + +     1.3       1.2               
F AB + + + +   +  +  + + +  + + + 1.4   2.5   1.9   4.7               
G AB + + + + + + +  + + + + + + + +  1.9   6.3   1.9   2.4               
I AB + + + + + + + +  + + + + + + + +     6.3       3.5               
J AB + + + + +  + + +  + + + + + + + 0.5 1.3 2.5       1.2               
M AB + + + + +  + + +  + + +  + + + 1.4 6.3 7.5       1.2               
N AB + + + + +  + +   + + +  + + +     1.3       1.2               
S AB + + + +   +    + + +  + + +     1.3       1.2               
X BB + +  + + + + +  +  + + + + +      1.3       1.2               
AE AB +  + + + +  +   + + + + + + + 1.4       1.9   2.4               
AF AA +  + +     +  + + +  + + + 20.5 15.0 5.0   30.8   10.6               
AG AA +  + +       + + +  + + + 3.3   2.5   2.9   16.5               
AI AB +  + + + +    + + + + + + + + 1.0   2.5   2.9   10.6               
NN11 BB +  + + + +  +    + + + + +  0.5       1.9                   
NN14 AB +  + +     +  + + + + + + + 2.4 2.5     1.0                   
1 AA +   +     +  + + +  + +  3.3                           
2 AA +   +     +  + + +  + + + 1.9                           
3 AB  +  +   +  +  + + +  + +  0.5                           
4 AA   + +     +  + + +  + + + 0.5                           
5 AB   + + +   +   + + +  + +  0.5                           
6 AB +  + +     +  + + + + + +  3.3                           
7 AB +  + + +    +  + + +  + +  0.5                           
8 AB  +  + + +   +  + + +  + +  0.5                           
9 AA  + + +     +  + + +  + + +     1.3                       
10 AA + + + +     +  + + +  + + +   5.0 2.5                       
11 AB +  + +   +  +  + + +  + + + 1.0                           
12 AB +   +  +   + + + + + + + +  0.5                         
13 AB  +  + + + + +   + + +  + +  0.5                         
14 AB +  + + +    + + + + +  + + +   1.3 2.5                      
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15 AB +  + +  +   +  + + + + + + + 1.0                           
16 AB + + + +     +  + + + + + + + 0.5                           
17 AB +  + + + +  + +  + + +  + +  0.5                           
18 AB +  + + + +   +  + + +  + + + 0.5                           
19 AB +  + + + +   + +  + + + + +  0.5                           
20 AB +  + + +   + +  + + +  + + + 0.5                           
21 AB +  + + + +   + + + + +  + +    3.8                         
22 AB + + + +   +  +  + + + + + +    2.5                         
23 AB +  + + + +   + +  + +  + + +   1.3                         
24 AB +  + + +   + + +  + +  + + +   1.3                         
25 AB  +  + +  + + +  + + +  + + +     5.0                       
26 AB + +  + + + + + +  + + +  + +  1.0                           
27 AB + + + + +   + +  + + + + + +  0.5                           
28 AB + +  + + + +    + + + + + + + 0.5                           
29 AB  +  + + + + +   + + + + + + + 0.5                           
30 AB +  + + + +   + + + + +  + + +   3.8                         
31 AB + + + + +  +  +  + + +  + + +   2.5                         
32 AB +  + + +   + +  + + + + + + +   2.5                         
33 AB + + + + +   +  + + + +  + + +   1.3                         
34 AB + + + + +   + +  + + +  + + +     2.5                       
35 AB  + + +  +  + + +  + + + + + +     1.3                       
36 AB +  + + +    + + + + + + + + +     1.3                       
37 AB + + + + + +  + +  + + +  + +  0.5                   
38 AB + + + + + +   + + + + +  + + +     1.3               
39 AB +  + + + +   + + + + + + + + + 2.4 1.3 3.8                       
40 AB + + + + + + +  +  + + +  + + + 0.5                           
41 AB + + + + + +  + +  + + + + + +  0.5                           
42 AB +  + + + + + + +  + + + + + +  0.5                           
43 AB + + + + + +   + + + + + + + +    2.5                         
44 AB  +  + + + + + +  + + + + + + +   2.5                         
45 AB  +  + + + + + + + + + +  + + +     2.5                       
46 AB +  + + +  +  + + + + + + + + +     1.3                       
47 AB  + + + + + +  + +  + + + + + +     1.3                       
48 AB  +  + + + + + + + + + + + + + +   1.3 1.3                       
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49 AB +  + + + + +  + + + + + + + + +     1.3                       
50 AB +  + + + +  + + + + + + + + + +     1.3                       
51 AB + + + + + + + + +  + + + + + + + 0.5   1.3                       
 
a Present study 
b Yawata et al. (2002a) Immunogenetics 54:543-550  
c Jiang et al. (2005) Tissue Antigens 65:556-563 
d  Rajalingam et al. (2002) Immunogenetics 53:1009-1019 
e  Hsu et al. (2002b) J Immunol 169:5118-5129 
f  Norman et al. (2001) Immunogenetics 52:195-205 
g  Witt et al. (1999) Transplantation 68:1784-1789 
h  Niokou et al. (2003) Hum Immunol 64:1167-1176 





Fig 3.3 KIR profiles in unrelated Singaporean individuals and profile comparison with other populations. A total of 98 different KIR genotypes 
were determined in three Singaporean populations, 47 of which were observed previously in other populations and 51 (1-51) of which are unique to 
our populations. Frequencies of various profiles are shown in percentage. ‘+’ indicates the presence of KIR gene and empty box indicates the absence 
of KIR gene. Profiles AA, AB, BB and C103-C106 were named according to the general models by Norman et al. (2001). Profiles C-AI were named 





The two most common KIR profiles observed in Singapore Chinese (n=210) were 
AA1 and AF, with 19.1% and 20.5% frequency respectively.  Frequencies of the 
remaining genotypes ranged from 0.5-5.2%.  For Singapore Malay (n=80), the most 
frequent profile was AA1 (16.3%) and the second most common profile was AF 
(15%).  The remaining genotypes were found with frequencies ranging from 1.3-
6.3%.  For Singaporean Indian (n=80), profile M with 7.5% frequency was prevailing.  
This was followed by AB5.1, G and I, which were equally common at 6.3% 
frequency.  The remaining genotypes were found at frequency ranging from 1.3-5%.   
 
Among the three Singaporean populations, Singapore Indian showed lower 
frequencies for various distinct KIR profiles, in part reflecting the increased frequency 
of genes characteristic of B haplotypes in this population.  The diversity of KIR 
genotypes in Singapore Indian appeared to be similar to north Indian Hindus, which 
described a large number of new profiles unique to that populations and an increase of 
B haplotype frequency.  
 
Profile AA1 consists of nine loci including six inhibitory genes KIR2DL1, 2DL3, 
2DL4, 3DL1, 3DL2 and 3DL3, two pseudogenes 2DP1 and 3DP1, and an activating 
gene 2DS4.  Profile AF contains of 10 loci, including all genes found in profile AA1, 
with an additional activating gene, namely KIR1D.  Both AA1 and AF correspond to 
the AA haplotypes.  Profile AA1 corresponds to haplotype AA homozygous state 
containing KIR2DS4 whereas profile AF corresponds to haplotype AA heterozygous 
state containing KIR2DS4 and 1D.  
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Profile AA1 was also predominant in most other populations including Japanese 
(56%), U.K. Caucasian (30.2%), Australian Caucasian (27.2%), Greek Caucasian 
(24.5%), Thai (35.3%), Palestinian (22.9%) and Vietnamese (42.4%).  Profile AF had 
only been described in two populations, namely Chinese Han and U.S.A. Caucasian. 
AF prevailed in Chinese Han (30.8%) and was the second most frequent profile in 
U.S.A. Caucasian (10.6%). 
 
All genotypes were assigned as having AA, AB or BB haplotype based on gene 
content.  Genotypes that contained the combination of A haplotype genes (KIR2DL1, 
2DL3, 3DL1, 2DS4 and 1D) and lacked B haplotype genes (KIR2DS1, 2DS2, 2DS3, 
2DS5, 2DL5 and 3DS1) were assigned as having two A haplotypes.  In contrast, 
genotypes that lacked A haplotype genes but had B haplotype genes were assigned as 
having two B haplotypes.  Those with the combination of A haplotype genes plus one 
or more B haplotyope genes were assigned as having one A haplotype and one B 
haplotype.  With this assignment, 74% of the haplotypes in Singapore Chinese was of 
group A while the remaining 26% was of group B.  The ratio of A: B haplotypes of 3:  
1 in Singapore Chinese was consistent to that of Chinese Han (Jiang et al., 2005), 
Japanese (Yawata et al., 2002a) and Korean (Whang et al., 2005).  The ratio of A: B 








3.7 Haplotype Studies 
 
3.7.1 KIR Genotypes  
KIR genotypes for 40 individuals from 11 unrelated Singapore Chinese families were 
determined based on the presence and absence of KIR genes and pseudogenes.  Fig 
3.4 illustrates genotype analysis of each individual from these 11 families in tables 
and the corresponding resolved parental haplotypes in figures following each table. 
All families included both parents with at least one child.  KIR genotypes were 
determined according to the models of Norman et al. (2001) and Hsu et al. (2002b).  
A total of 19 different genotypes were identified in the family panel of 40 individuals, 
two of which were unique.  The remaining genotypes occurred from two to eight 
times.  
 
Genotypes contained between nine and 15 genes, with a mean of 12 genes. Two most 
common genotypes were genotypes AA1 and AA2.1, both occurred with 20% 
frequencies.  Genotype AA1 consisted of nine genes and corresponded to A 
haplotypes in a homozygous state containing KIR2DS4 (haplotype A-2DS4) while 
genotype AA2.1 consisted of 13 genes corresponds to group A and B haplotypes in a 
heterozygous state.  Other genotypes were considerably less frequent, appeared 
between one and six times in our family panel.  The distribution of genotypes, in 




















Fam. 1 3DL3 2DS2 2DL2 2DL3 2DP1 2DL1 3DP1 2DL4 3DL1 3DS1 2DL5 2DS3 2DS5 2DS1 2DS4 1D 3DL2 Genotype Haplotype 
F +   + + + + + +      +  + AA1 2/2 
M +   + + + + + + + +  + + +  + AA2.1 2/5 
C1 +   + + + + + +      +  + AA1 2/2 
C2 +   + + + + + +      +  + AA1 2/2 
C3 +   + + + + + + + +  + + +  + AA2.1 2/5 
  2DL2      3DS1     2DS4  
3DL3 2DS2  2DP1 2DL1 3DP1  2DL4  2DL5 2DS3 2DS5 2DS1  3DL2 
  2DL3      3DL1     1D  
Fam. 2 3DL3 2DS2 2DL2 2DL3 2DP1 2DL1 3DP1 2DL4 3DL1 3DS1 2DL5 2DS3 2DS5 2DS1 2DS4 1D 3DL2 Genotype Haplotype 
F +   + + + + + + + + +  + +  + AA8 2/6 
M + + + + + + + + +  + +   +  + AB9 2/19 
C1 +   + + + + + + + + +  + +  + AA8 6/2 
C2 + + + + + + + + +  + +   +  + AB9 2/19 
C3 +   + + + + + +      +  + AA1 2/2 
  2DL2      3DS1     2DS4  
3DL3 2DS2  2DP1 2DL1 3DP1  2DL4  2DL5 2DS3 2DS5 2DS1  3DL2 
  2DL3      3DL1     1D  
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Fam. 4 3DL3 2DS2 2DL2 2DL3 2DP1 2DL1 3DP1 2DL4 3DL1 3DS1 2DL5 2DS3 2DS5 2DS1 2DS4 1D 3DL2 Genotype Haplotype 
F +   + + + + + +      +  + AA1 2/2 
M +   + + + + + + + +  + + +  + AA2.1 2/5 
C1 +   + + + + + +      +  + AA1 2/2 












Fam. 3 3DL3 2DS2 2DL2 2DL3 2DP1 2DL1 3DP1 2DL4 3DL1 3DS1 2DL5 2DS3 2DS5 2DS1 2DS4 1D 3DL2 Genotype Haplotype 
F +   + + + + + +      + + + AF 1/2 
M + + + + + + + + + + + +   + + + J 1/21 
C1 + + + + + + + + + + + +   +  + AB10 2/21 
C2 + + + + + + + + + + + +   +  + AB10 2/21 
  2DL2      3DS1     2DS4  
3DL3 2DS2  2DP1 2DL1 3DP1  2DL4  2DL5 2DS3 2DS5 2DS1  3DL2 
  2DL3      3DL1     1D  
  2DL2      3DS1     2DS4  
3DL3 2DS2  2DP1 2DL1 3DP1  2DL4  2DL5 2DS3 2DS5 2DS1  3DL2 
  2DL3      3DL1     1D  
2 
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Fam. 5 3DL3 2DS2 2DL2 2DL3 2DP1 2DL1 3DP1 2DL4 3DL1 3DS1 2DL5 2DS3 2DS5 2DS1 2DS4 1D 3DL2 Genotype Haplotype 
F +   + + + + + + + +  + + +  + AA2.1 2/5 
M +   + + + + + + + +  + + +  + AA2.1 2/5 
C1 +   + + + + + + + +  + + +  + AA2.1 2/5 
C2 +   + + + + + + + +  + + +  + AA2.1 2/5 
  2DL2      3DS1     2DS4  
3DL3 2DS2  2DP1 2DL1 3DP1  2DL4  2DL5 2DS3 2DS5 2DS1  3DL2 
  2DL3      3DL1     1D  
Fam. 6 3DL3 2DS2 2DL2 2DL3 2DP1 2DL1 3DP1 2DL4 3DL1 3DS1 2DL5 2DS3 2DS5 2DS1 2DS4 1D 3DL2 Genotype Haplotype 
F + + + + + + + + +      + + + F 2/15 
M +   + + + + + +      +  + AA1 2/2 
C + + + + + + + + +      + + + F 2/15 
  2DL2      3DS1     2DS4  
3DL3 2DS2  2DP1 2DL1 3DP1  2DL4  2DL5 2DS3 2DS5 2DS1  3DL2 
  2DL3      3DL1     1D  
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Fam. 8 3DL3 2DS2 2DL2 2DL3 2DP1 2DL1 3DP1 2DL4 3DL1 3DS1 2DL5 2DS3 2DS5 2DS1 2DS4 1D 3DL2 Genotype Haplotype 
F + + + + + + + +  + +  + +   + AB103.1 5/14 
M +   + + + + + + + + +  + +  + AA8 2/6 













Fam. 7 3DL3 2DS2 2DL2 2DL3 2DP1 2DL1 3DP1 2DL4 3DL1 3DS1 2DL5 2DS3 2DS5 2DS1 2DS4 1D 3DL2 Genotype Haplotype 
F +   + + + + + + + + +  +  + + AE 1/6 
M + + + + + + + +  + + + + +   + AB7.1 6/14 
C + + + + + + + +  + + + + +   + AB7.1 6/14 
  2DL2      3DS1     2DS4  
3DL3 2DS2  2DP1 2DL1 3DP1  2DL4  2DL5 2DS3 2DS5 2DS1  3DL2 
  2DL3      3DL1     1D  
  2DL2      3DS1     2DS4  
3DL3 2DS2  2DP1 2DL1 3DP1  2DL4  2DL5 2DS3 2DS5 2DS1  3DL2 
  2DL3      3DL1     1D  
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Fam. 10 3DL3 2DS2 2DL2 2DL3 2DP1 2DL1 3DP1 2DL4 3DL1 3DS1 2DL5 2DS3 2DS5 2DS1 2DS4 1D 3DL2 Genotype Haplotype 
F +   + + + + + +      + + + AF 1/2 
M + + + + + + + + +      + + + F 1/16 or 2/15 















Fam. 9 3DL3 2DS2 2DL2 2DL3 2DP1 2DL1 3DP1 2DL4 3DL1 3DS1 2DL5 2DS3 2DS5 2DS1 2DS4 1D 3DL2 Genotype Haplotype 
F +   + + + + + + + +  + + +  + AA2.1 2/5 
M +   + + + + + + + + +  +  + + AE 1/6 
C +   + + + + +  + + + + +   + AA9 5/6 
  2DL2      3DS1     2DS4  
3DL3 2DS2  2DP1 2DL1 3DP1  2DL4  2DL5 2DS3 2DS5 2DS1  3DL2 
  2DL3      3DL1     1D  
  2DL2      3DS1     2DS4  
3DL3 2DS2  2DP1 2DL1 3DP1  2DL4  2DL5 2DS3 2DS5 2DS1  3DL2 
  2DL3      3DL1     1D  
1D L13 
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Fam. 11 3DL3 2DS2 2DL2 2DL3 2DP1 2DL1 3DP1 2DL4 3DL1 3DS1 2DL5 2DS3 2DS5 2DS1 2DS4 1D 3DL2 Genotype Haplotype 
F + + + + + + + + +      + + + F 1/16 or 2/15 
M +   + + + + + +      + + + AF 1/2 



















Fig 3.4 Family studies: KIR genotype profiles and the corresponding putative haplotypes of 40 samples from 11 Singapore Chinese 
families. Genotype profiles for each family member are shown in table. F indicates father, M indicates mother and C indicates child. 
Nomenclature system from Norman et al. (2001) was used to describe the genotypes that do not include KIR1D. For genotypes without KIR1D: 
Profiles that include KIR2DL1 and KIR2DL3 but not KIR2DL2 are termed AA, vice versa are BB, those that include all three loci are termed 
AB. Nomenclature system from Hsu et al. (2002b) was used to describe genotypes that include KIR1D, which were denoted with one or two 
alphabets without a numerical suffix. Figure below each table shows the corresponding putative parental haplotypes (two paternal haplotypes 
followed by two maternal haplotypes) identified based on the haplotype models defined by Hsu et al. (2002b). Haplotypes are assigned number 
codes and belonged to either group A or B as indicated. Shaded boxes represent framework genes. Typing for alleles are indicated within boxes.
  2DL2      3DS1     2DS4  
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  2DL3      3DL1     1D  
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3.7.2 KIR Haplotype  
Haplotype analysis is favourable and widely used in genetic association studies. 
Although haplotype-based analysis method is a powerful tool, the large number of 
distinct haplotypes may reduce its efficiency.  The haplotype predictions are given in 
the following way.  Every individual is represented by two strings, which correspond 
to its two haplotypes.  The different blocks of genes/ alleles are separated by 
horizontal lines.  Analysis of KIR genotypes in the family panel revealed independent 
segregation of KIR haplotypes (Fig 3.4).  A total of eight different haplotypes were 
resolved in 22 Singapore Chinese parents based on the haplotype model proposed by 
Hsu et al. (2002b).  In this study, KIR genotypes of most parents could be resolved by 
gene content into corresponding pairs of haplotypes AA, AB or BB. However, the 
genotype F of mother from family 10 and father from family 11 could be resolved 
into two different combinations of haplotypes (A1 and B16 or A2 and B15) and was 
confirmed by segregation analysis. F or both cases, we chose the haplotypes with 
higher frequencies for analysis of data, namely A2 and B15.  It was noted that the 
same haplotype combination of two haplotypes A2 and the combination of haplotypes 
A2 and B5 segregated in two different families, namely family 1 and family 4. 
 
Two of the haplotypes found in this study were unique, with the remaining haplotypes 
each observed from two to 20 times.  The number of loci in haplotypes varied from 
nine for group A haplotype to 12 in the case of group B haplotype, with a mean of 10 
genes.  KIR3DL3 and 3DL2 at both ends of the KIR gene cluster and in the middle, 
3DP1 and 2DS4 are the framework genes, present in all haplotypes.  All haplotypes 
encode an inhibitory KIR for group 1 HLA-C epitope, either KIR2DL3 present on 
group A and some group B haplotypes, or 2DL2 present mostly on group B 
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haplotypes.  All haplotypes also encode for receptor of HLA-B Bw4 epitope, either 
KIR3DL1 that was present on group A haplotypes or its activating counterpart 3DS1 
present on group B haplotypes.  
 
The most abundant haplotype observed in Singapore Chinese families was haplotype 
A2 (haplotype A-2DS4), with approximately 48% frequency and consisted of nine 
genes including KIR3DL3, 2DL3, 2DP1, 2DL1, 3DP1, 2DL4, 3DL1, 2DS4 and 3DL2. 
Two second most common haplotypes were A1 and B5, each occurred six times. 
Haplotype A1 consisted of nine genes including KIR3DL3, 2DL3, 2DP1, 2DL1, 
3DP1, 2DL4, 3DL1, KIR1D and 3DL2, corresponds to haplotype A1 (haplotype A-
1D).  Haplotype B5 consisted of 11 genes including KIR3DL3, 2DL3, 2DP1, 2DL1, 
3DP1, 2DL4, 3DS1, 2DL5, 2DS5, 2DS1 and 3DL2.  The remaining haplotypes 
occurred from one to five times.  
 
3.7.3 Comparison of Haplotype Frequency 
KIR haplotype frequencies observed in Singapore Chinese were compared to those 
reported in several other populations, including Korean (Whang et al., 2005), Chinese 
Han (Jiang et al., 2005) and Caucasian (Hsu et al., 2002a) (Table 3.4).  Haplotype A2 
with 45.5% frequency was predominant in our population, comparable with Korean 
and Chinese Han.  Haplotype A2 was the prevalent haplotype in Korean and Chinese 
Han as well, with frequencies of 53.9% (Whang et al., 2005) and 54.6% (Jiang et al., 
2005) respectively. In contrast, haplotype A2 accounted for only 11.8% of all KIR 
haplotypes in Caucasian (Hsu et al., 2002a).  For Caucasian population, haplotype A1 
with frequency of 38.8% (Hsu et al., 2002a) was most prevailing. 
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Table 3.4 KIR haplotype frequencies in Singapore Chinese and other populations  
 
Singapore Chinese a Korean b  Chinese Han c Caucasian d KIR 
Haplotype (n=44) (n=308) (n=198) (n=170) 
A1 0.136 0.195 0.207 0.388 
A2 0.455 0.539 0.546 0.118 
B3 - 0.006 0.035 0.077 
B4 - 0.023 0.015 0.065 
B5 0.136 0.101 0.106 0.124 
B6 0.114 0.068 0.056 0.024 
B8 - - - 0.041 
B9 - - - 0.035 
B11 - - - 0.012 
B12 0.046 (B14) 0.019 0.01 - 
B13 0.068 (B15) - 0.005 0.018 
B14 - - - 0.024 
B15 - - 0.005 - 
B17 - - 0.005 0.024 
B18 - 0.006 - - 
B19 - - - 0.018 
B20 0.023 (B21) - - 0.012 
Others - 0.041 0.015 0.024 
 
a Present study  
b Whang et al. (2005) Human Immunol 66: 146-154 
c Jiang et al. (2005) Tissue Antigens 65: 556-563 
d Hsu et al. (2002a) Immunol Rev 190: 40-52 
Haplotypes are named based on haplotype model suggested by Hsu et al. (2002a) 




Both haplotypes A1 and A2 consist of nine genes and are subgroups of the group A 
haplotypes.  Haplotype A1 contained KIR1D (gene variant of KIR2DS4) whereas 
haplotype A2 contained the full-length 2DS4.  Data implied that group A haplotype in 
general is predominant in most populations, including Singapore Chinese in this 
study, Korean (Whang et al., 2005), Chinese Han (Jiang et al., 2005) and Caucasian 
(Hsu et al., 2002b).  The B haplotypes were more diverse; each occurred with much 
lower frequencies, ranged from 0.023-0.136 in Singapore Chinese, 0.006-0.101 in 
Korean, 0.005-0.106 in Chinese Han and 0.012-0.124 in Caucasian. 
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3.8 Case-Control Studies: KIR Frequencies in NPC Patients and Controls 
The frequencies of 17 KIR genes and pseudogenes in 122 NPC patients and 210 
healthy individuals were illustrated in Fig 3.5.  Both NPC patients and controls were 
of Singapore Chinese ethnicity.  Framework KIR genes 3DL3, 2DL4 and 3DL2 were 
present in all patient samples tested, consistent with controls.  Pseudogenes 2DP1 and 
3DP1 were both observed with 99.2% frequencies in NPC patients, comparable to 
100% frequencies observed in controls.  Most of the remaining genes occurred with 
similar frequencies in both the patients and controls without significant differences, 
except for activating KIR2DS2 and inhibitory 2DL1.  
 
KIR2DS2 was present in 28.7% of NPC patients, but only in 18.1% of healthy 
controls (p=0.028, OR=1.82, 95%CI=1.08, 3.08), showing significantly higher 
frequency in patients compared to controls.  In contrast, frequency of inhibitory 
KIR2DL1 was significantly lower in patients than controls. 87.7% of the patients were 
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Fig 3.5 Frequencies of 17 KIR genes in 122 Singapore Chinese NPC patients and 210 Singapore Chinese controls. Filled bars designate 













































CHAPTER 4. DISCUSSION 
 
4.1 Distribution of KIR Genes  
In this study, the distribution of 17 KIR sequences in healthy and unrelated 
Singaporean populations of 210 Singapore Chinese, 80 Singapore Malays and 80 
Singapore Indians was determined by PCR-SSP typing method.  Five KIR genes were 
present in 100% of all three populations tested.  These 100% genes included the 
ubiquitous framework loci (KIR3DL3, 3DP1, 2DL4 and 3DL2) previously defined by 
Hsu et al. (2002a) and Wilson et al. (2000), as well as the non-framework pseudogene 
KIR2DP1, also known as KIR-Z located downstream of 2DL1 and upstream of 
2DL2/2DL3.  The remaining 12 genes were present in a range of frequencies (15.2-
96.2%), with a variation of KLFs (0.08-0.80) across the three Singaporean 
populations.  Among the non-ubiquitous genes, KIR2DS2, 2DL2, 2DL5 and 2DS5 
exhibited the greatest significant difference among the three ethnic groups.  Three of 
these gene KIR2DS2, 2DL2 and 2DL5 are known constituents of B haplotypes and 
were found to be in linkage disequilibria in our populations (see below).  
 
Although the three study populations are all Singaporean, distinct ethnic origins are 
the likely cause for the observed significant differences in frequencies between 
populations.  The greatest difference in frequency between Singapore Chinese and 
Singapore Indian was 48.3% (for KIR2DL2), which was higher than that between 
Singapore Malay and Singapore Indian (28.7% for KIR2DS2) and 22% (for 
KIR2DL2) between Singapore Chinese and Singapore Malay. T his shows that 
Singapore Chinese and Singapore Indian could be more diverse ethnically, compared 
to Singapore Chinese and Singapore Malay, or Singapore Malay and Singapore 
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Indian.  Among three Singaporean populations, Singapore Indian showed higher 
frequency of all genes charactieristic of B haplotypes, indicating more diverse KIR 
genotype profiles and a relatively higher frequency of B haplotypes compared to 
Singapore Chinese and Singapore Malay. 
 
Our populations may have yet uncharacterized KIR genes and alleles.  Future 
investigation with high-resolution and refined typing systems may reveal a more 
detailed distribution of KIR genes in our populations.  Nevertheless, we have shown 
that KIR locus frequencies can be significantly different between ethnic populations 
and clearly demonstrated that KIR gene family is fairly diverse. 
 
4.2 Linkage Disequilibria Correspond to Haplotypes 
LD analysis identified several strong positive and negative associations in 
Singaporean populations.  We observed 16 significant LD values across all three 
populations.  There were two groups of genes positively linked to each other in all 
three populations, the first group consisted of KIR2DS2, 2DL2, 2DL5 and 2DS3; and 
the second group included KIR3DS1, 2DS5 and 2DS1, each of which was also 
positively associated with 2DL5.  These genes correspond to group B haplotype and 
are consistent with the suggestion that KIR2DL5 (the most recently described member 
of the KIR family) is associated with B haplotype.  In addition, KIR2DL1 and 2DL3 
that corresponds to A haplotype were found to be in positive LD in all three 
Singaporean populations.  These two genes have always been described as being 
present together on a number of the deduced haplotypes reported in other studies.  
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On the other hand, negative associations happen for alleles of the same locus as well 
as genes that rarely occur on the same haplotype.  Strong negativity between 
KIR2DS1 and KIR1D; KIR3DL1 and 2DL5; and KIR3DL1 and 2DS1 observed in all 
three Singaporean populations were consistent with negative LD between two genes 
of A and B haplotypes.  
 
Other previously described LDs (Cook et al, 2003; Norman et al., 2001) were found 
in only one or two, but not all three Singaporean populations.  For instance, besides 
the 16 similar LD in all three populations, significant LD of KIR2DS2 with 2DL3, 
2DL2 with 2DL3, 2DL2 with 2DL1, 2DL3 with 2DS3, 2DL1 with 2DS3, 2DL3 with 
2DS4 and 3DL1 with KIR1D were present in Singapore Malay and Singapore Indian.  
Positive LD of KIR3DL1 with 2DL5 and 3DS1 with 2DS3 were present in Singapore 
Chinese and Singapore Malay while negative LD of 3DL1 and 3DS1 was observed in 
Singapore Chinese and Singapore Indian.  On the whole, all patterns of LD we 
established correspond to haplotypes and were consistent with findings described in 
other populations previously published.  
 
4.3 Comparable KIR Frequencies with Other Asian Populations 
KIR gene frequencies in our populations were compared with those reported in 12 
other populations.  All framework loci that were present in 100% of Singaporean 
populations were in agreement with almost all other populations previously studied, 
except Shanghai Chinese (Zhang et al., 2003) for KIR3DP1.  Besides the four 
framework KIRs that are ubiquitous and known to be exhibited by nearly all 
haplotypes, a non-framework pseudogene KIR2DP1 was also present in 100% of our 
populations, consistent with Japanese (Yawata et al., 2002a) and Korean (Whang et 
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al., 2005).  KIR2DP1, also known as KIR-Z contains two pseudoexons and one exon 
encoding Ig domains and it is closely related to 2DL1 and 2DL2/2DL3 in terms of 
genomic organization and nucleotide sequence (>97% homology).  
 
In general, KIR gene frequencies in Singapore Chinese were highly comparable to 
those of Chinese Han (Jiang et al., 2005), Japanese (Yawata et al., 2002a) and Korean 
(Whang et al., 2005).  However, despite great compatibilities, several inconsistencies 
in gene frequencies were observed between Singapore Chinese and these populations 
explainable by their distinct origins.  Singapore Chinese exhibited discrepancies 
ranging from 0.5-9.5% with Chinese Han, 0.4-9.8% with Japanese and 0.3-11.4% 
with Korean.  Singapore Chinese are defined as Chinese living in Singapore, 
originating mostly southern China such as Guangzhou and Fuzhou and are made up of 
three main dialect groups Cantonese, Hokkien and Teochew.  In addition to 
geographical differences, the disparities in KIR gene frequencies between these two 
Chinese populations could be due to different sample size, variations in typing 
method and efficiency.  
 
KIR frequencies between Singapore Indian and north Indian Hindus (Rajalingam et 
al., 2001) were highly comparable, despite several discrepancies ranging from 0.4% 
for KIR2DL5 and 2DS1 to 19.7% for 2DL3.  Geographical difference and region of 
origin would explain the dissimilarities in characteristics.  The majority of Singapore 
Indian is the third or fourth generations of Hindu Tamils migrated mostly from 
southern India during colonial era.  While a majority of the migrants were from south 
India, there were also Sikhs, Punjabis, Gujaratis, Bengalis and Parsis who are 
included in this ethnic category.  Data also showed that Singapore Malay shared some 
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similarities with the Thai (Norman et al., 2001), a Southeast Asian population, 
although both populations have distinct origins.  However, despite overall similarities, 
differences in gene frequencies ranging from 0.5% for KIR2DL2 to 12.7% for 2DS2, 
were observed.  
 
4.4 KIR Profiles  
Diversity in KIR repertoire is influenced by the polygenic and polymorphic nature of 
the KIR family.  To date, over 110 KIR profiles have been reported in several studies. 
New profiles are being identified and it is expected that more will be found in the 
future.  Ninety-eight distinct KIR profiles were observed in our populations, 51 of 
which had not been described in other populations and appear to be characteristic of 
our populations.  These novel profiles were present in 25-33% of our populations. 
This variety is predominantly due to loci for the non-inhibitory KIRs and about 90% 
of novel genotypes profiles are made up of combination of A and B haplotypes. 
Heterozygous combination of a group A and B haplotype always reflect a higher 
number of activating genes and in most cases also of inhibitory genes in a genotype. 
 
Genotypes were determined according to the nomenclature system from Norman et al. 
(2001).  Data in our samples include typing for KIR1D, which is not tested in most 
other populations except in U.S.A. Caucasian by Hsu et al. (2002b) and in Chinese 
Han by Jiang et al. (2005).  Thus, the nomenclature systems used by these two groups 
were also adopted in profile analysis. 
 
The most frequently observed profile so far reported has been AA1, which comprises 
of nine genes and includes the fewest non-inhibitory KIR loci.  AA1 was prevalent in 
  78
Caucasian (Witt et al., 1999; Norman et al., 2001; Niokou et al., 2003), Japanese 
(Yawata et al., 2002a), Palestinian (Norman et al., 2001), Thai (Norman et al., 2001) 
and Vietnamese (Toneva et al., 2001) and remained the most frequently observed 
profile in Singapore Chinese and Singapore Malay although to a lesser extand 
Singapore Indian in this study.  It was not the most common profile in north Indian 
Hindus (Rajalingam et al., 2002) and was rarely observed in Australian Aborigines 
(Toneva et al., 2001).  It still remains to be determined whether AA1 profile offers a 
protective advantage or is merely a consequence of unrelated environmentally 
induced population bottlenecks; which may be severe in some cases (Reich et al., 
2001).  KIR profiling is a useful method employed in this study. However, the 
drawbacks of KIR profiling are that gene copy number and post-translational 
modifications of KIRs such as methylation are not captured by this method. 
 
On assignment of haplotype combinations to genotypes, A haplotypes prevailed at 
74% frequency against 26% frequency for B haplotypes in Singapore Chinese.  This 
ratio of A: B haplotype was consistent with that of some other Asian populations 
including Chinese Han (Jiang et al., 2005), Japanese (Yawata et al., 2002a) and 
Korean (Whang et al., 2005).  Singapore Malay also exhibited a higher frequency of A 
haplotype, with A: B ratio of 2.4: 1.  In contrast, Singapore Indian had a near equal 
ratio of 1.3: 1, a balance that may not be fortuitous but constitute evidence of some 
form of balancing selection between the two groups of haplotypes. 
 
4.5 Haplotype A Predominates in Singapore Chinese  
In haplotype studies, estimated KIR haplotypes in Singapore Chinese had been 
defined for the first time by determining the presence and absence of 17 KIR genes 
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and pseudogenes in several families.  The two most common genotypes observed 
were AA1 and AA2.1. P rofile AF, one of the most frequently observed genotype in 
profile analysis, was observed with 7.5% frequency in family samples.  The sum of 
frequency for three profiles AA1, AA2.1 and AF was 47.5%, comparable to their 
combined frequencies in KIR profiles analysis of random Singapore Chinese of 44.8% 
(AA1 =19.1%, AF=20.5% and AA2.1=5.2%). 
 
All genotypes could be resolved into existing haplotypes based on haplotypes models 
suggested by Hsu et al. (2002b) unambiguously.  Eight different KIR haplotypes with 
varying numbers and kind of genes were determined through segregation analysis in 
the family panel.  All haplotypes belong to either group A or B haplotypes.  Group A 
haplotypes are defined as haplotypes that contained only one activating gene 
KIR2DS4/1D whereas group B haplotypes are defined as containing more variable 
gene combinations and characterized by the presence of one or more of the following 
genes KIR2DS2, 3DS1, 2DL5, 2DS3, 2DS5, and 2DS1.  Group A haplotype diversity 
is mostly allelic variations, whereas B haplotype diversity is mostly different in gene 
content.  
 
In this study, A haplotypes that consisted of a set of nine genes were found in all 11 
families studied while B haplotypes can have number of genes between 10 and 12. 
Though divergent, haplotypes in Singapore Chinese families demonstrated several 
common features that might help to define essential components of the KIR 
haplotypes.  Firstly, all five genes that are found present in 100% of Singaporean 
populations, namely KIR3DL3, 2DP1, 3DP1, 2DL4 and 3DL2 are present in all 
haplotypes.  Secondly, all haplotypes contain a gene encoding receptor for group 1 
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HLA-C, either KIR2DL2 or 2DL3, consistent with their allelic relationship.  Thirdly, 
all haplotypes possess either gene KIR3DL1 that encode receptor that binds HLA with 
Bw4 epitopes or its activating counterpart 3DS1 of which the ligand is currently 
unknown.  Lastly, all haplotypes contain at least one activating KIR gene.  The most 
frequently found being KIR2DS4, the prevalent activating gene in Singaporean 
populations, with 77.5-95% frequencies. It is the only KIR stimulatory gene that has 
an ortholog in the chimpanzee (Khakoo et al., 2000).  In haplotypes lacking KIR2DS4, 
its gene variant or three or four other activating genes are present, implying that 2DS4 
and its alleles fulfills a specific function which is not replaced by one of the other 
activating KIRs.  However, the exact function and ligand specificity of this gene is 
currently unknown. 
 
Our data of haplotype analysis is consistent with the presence of two major groups of 
haplotypes and the prevalence of A haplotypes.  Segregation analysis showed that A 
haplotypes were observed at 59.1% frequency in our Singapore Chinese family panel. 
45.5% of which was observed for haplotype A2 (A-2DS4) while the other 13.6% was 
observed for haplotype A1 (A-1D).  Higher percentage of haplotype A2 (A-2DS4) than 
haplotype A1 (A-1D) was expected because the KIR2DS4 gene occurred at a higher 
frequency than KIR1D gene in Singapore Chinese as shown in population study. 
Comparison of haplotype frequency with other populations showed that haplotype A2 
(A-2DS4) dominates in our population, comparable to two other Asian populations 
including Korean (Whang et al., 2005) (53.9%) and Chinese Han (Zhang et al., 2003) 
(54.6%).  In contrast, haplotype A1 (A-1D) was the most prevailing in Caucasian (Hsu 
et al., 2002a), consistent with population gene frequency where KIR1D was more 
predominant  (78.8% for KIR1D vs. 35.3% for 2DS4) in this population.  According 
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to the definition of B haplotypes, more than 15 different haplotypes were resolved, all 
happened with very low frequencies compared to A haplotypes.  
 
As the ratio of A to B haplotypes increases in a population, so does the average ratio 
of inhibitory to activating receptors per individual (Jiang et al., 2005; Yawata et al., 
2002a; Whang et al., 2005).  Under pressure from certain pathogens, B haplotypes 
may be favored over A haplotypes because their KIRs more effectively activate NK 
cells and/or T cells against the pathogen, but they may also tend towards undesirable 
autoimmune defects, as suggested by two recent studies on arthritis (Namekawa et al., 
2000; Kogure et al., 2001).  In contrast, KIRs of A haplotypes may provide stronger 
tolerance to self, while being less effective in the activation of responses directed at 
pathogens.  Thus, two types of haplotypes complement each other and provide the 
basis for a balance selection.  
 
4.6 Effects of KIR Genes in NPC 
Genetic susceptibility is known to be an important factor in nasopharyngeal 
carcinoma (NPC).  Many HLA class I alleles have been associated with NPC.  On the 
other hand, little is known about KIR, the NK cell receptor that binds HLA class I 
molecules in an immune response against virus infection.  We studied the influence of 
KIR genes on the susceptibility to develop NPC and demonstrated some significant 
differences in the KIR frequencies between patients with NPC and ethnically matched 
healthy controls. 
 
We investigated the association between KIR genes and susceptibility to NPC by 
comparing the frequencies of 17 KIR genes in 122 Singapore Chinese NPC patients 
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and 210 healthy controls.  Most individuals possess inhibitory KIR genes, encoding 
receptors for all three major HLA class I epitopes.  KIRs specific for Cw group 1 
allotypes (KIR2DL2/3) were found in most individuals; KIR specific for Cw group 2 
(KIR2DL1) was present in 96.2% of individuals tested.  KIR specific for Bw4 epitope 
(KIR3DL1) was present in 95.7% of individuals tested.  Among 17 KIRs typed, two 
have shown significant differences in frequencies between NPC patients and controls. 
Activating KIR2DS2 had a significantly higher frequency (OR=1.82) in patients 
compared to controls whereas inhibitory 2DL1 had a significantly lower frequency 
(OR=0.28) in NPC patients compared to controls.  Although potential protective 
functions for activating KIRs in diseases have been hypothesized, both observations 
are in accordance with the study performed by Kovacic et al. (2005).  In this study, a 
hypothesis on the possible roles of KIRs in pathogenesis and viral-associated cancers 
has been proposed.  The hypothesis suggests that activating KIRs and/or reduction of 
inhibitory KIRs may increase the risk of disease development through non-specific 
inflammatory responses such as oxidative DNA damage, triggered by activated NK 
cells.  It is suspected that activating KIR2DS2 and lack of inhibitory KIR2DL1 in 
NPC patients may result in susceptibility to NPC in this way.  However the exact 
nature and function of most KIRs in immune responses remain unknown.  Especially 
when the ligands of activating KIRs are unclear.  This is more so considering a 
complex repertoire of polymorphic KIRs used by NK cells to interpret their 
environment. 
 
4.7 Future Consideration 
KIR gene frequencies, genotypes and haplotypes in Singaporean populations are 
studied for the first time using gene-level typing method.  This approach tested for all 
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genes and pseudogenes identified so far but did not discriminate all of the known KIR 
alleles or gene variants.  Further investigation needs to be accomplished in order to 
fully understand the biologic implications of the variety of KIR repertoires possessed 
by individuals, as well as distribution of the KIR locus profiles and their functional 
significance.  Subtyping of KIR gene variants and larger sample size would permit 
resolution of different alleles and increase the diversity of genotype profiles.  Larger 
numbers or extended family samples would need to be studied to determine the 
genomic organization of the putative haplotypes.  Expression study or protein assay 
on KIR genes that were found associated with NPC will be useful for further 
evaluation of the associations to provide us with better knowledge on roles of KIR on 
development of NPC and better understanding of the underlying mechanisms. 
 
In summary, our findings demonstrated that variations in KIR gene frequencies exist 
among three Singaporean populations of distinct origins.  Comparison with reported 
frequencies by other populations showed that each of the Singaporean ethnic group 
exhibited similarities with some Asian populations while greater diversity exists 
between Singaporean populations and those ethnically defined and geographically 
distant populations in the world.  Ninety-eight distinct KIR profiles were observed in 
our populations, 51 of which were novel.  Ratio of A: B haplotype in Singapore 
Chinese was 3: 1, comparable to some Asian populations.  In haplotype studies on 
several Singapore Chinese families, 19 different KIR genotypes and eight different 
KIR haplotypes were determined.  Haplotype A2 prevails in our population, 
comparable to Korean and Chinese Han.  Data of case-control studies suggested that 
inhibitory and activating KIRs seem to have opposing effects on NPC risk in 
  84
Singapore Chinese, activating one increases NPC risk while inhibitory one decreases 
NPC risk.   
 
This is the first study of KIR gene distribution in the Singaporean populations. This 
work could serve as a reference for future research in the understanding of KIRs, such 
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Appendix I: Preparation of Media, Buffer and Solutions 
 
Media 
All media and some solutions used in this study were sterilized by autoclaving at 121 
°C for 15 minutes. 
 
 
Buffer and Solutions for Preparation of Cell Culture 
 
RPMI 1640 Medium 
 
RPMI 1640 medium powder (Gibco RBL, USA) 1 packet 
 
Hepes          35.7 g 
 
L-glutamine              3 g 
 
Pyruvic acid sodium salt         1.1 g 
   
Glucose            10 g 
  
NaHCO3            20 g 
 
 
Dissolve one packet of RPMI powder in 5 L of ddH2O, and add Hepes, L-glutamine, 
pyruvic acid sodium salt and glucose. Then add NaHCO3 (separately dissolved) and 
adjust the pH to 7.2. Add another 5 L of ddH2O to the mixture. Sterilize the mixture 
by double filtration through a 0.22-µm membrane. Aliquot the medium and store at 4 
°C. 
 
Fetal Calf Serum (FCS) 
Thaw 500 ml of fetal calf serum (Cytosystems, Australia) at 37 °C in a water bath and 
heat inactivate it at 65 °C for 30 minutes. Aliquot and store at 4 °C. 
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R10 Medium 
PIS         2 ml 
FCS       20 ml 
 
RPMI       make up to 200 ml 
 
Store at 4 °C. 
 
Freezing Medium  
FCS       10 ml 
 
DMSO       10 ml 
 
RPMI       make up to 100 ml 
 
Store at 4 °C. 
 
10x Phosphate Buffered Saline (PBS) 
KCl         20 g 
 
KH2PO4        20 g 
 
NaCl       800 g 
 
Na2HPO4      115 g 
 
ddH2O       make up to 10 L 
 
Autoclave followed by filter and store at 4 °C. 
 
Buffer and Solutions for Preparation of DNA 
 
10x PBS (Phosphate Buffered Saline) 
KCl         20 g 
 
KH2PO4        20 g 
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NaCl       800 g 
 
Na2HPO4      115 g 
 
ddH2O       make up to 10 L 
 
Autoclave followed by filter and store at 4 °C 
 
Buffer and Solutions for PCR 
 
10x dNTP Stock Solution 
dATP (100 mM)      2 mM   30 µl 
dTTP (100 mM)      2 mM   30 µl 
 
dCTP (100 mM)      2 mM   30 µl 
 
dGTP (100 mM)     2 mM   30 µl 
 
Tris HCl EDTA (pH 7.0)       1380 µl 
  
Prepare Tris HCl EDTA from stock solution of 3 mM of Tris HCl (pH 7.0) and 0.1 
mM EDTA. Store at -20 °C. 
 
Buffer and Solution for Preparation of Electrophoresis 
 
10x TBE (Tris-borate buffer) 
Tris base      108 g 
Boric acid        55 g  
 
EDTA        9.3 g 
 
ddH2O       make up to 1 L 
 
Autoclave and store at room temperature. 
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Ficoll Loading Buffer 
Bromophenol Blue     0.25 g 
Orange G      0.25 g 
 
Ficoll           15 g 
 
EDTA (0.5M)         8 ml   
 
ddH2O       make up to 100 ml 
 
Store at room temperature. 





































Homo sapiens killer cell immunoglobulin-like receptor, two domains, 
long cytoplasmic tail, 1 (KIR2DL1), mRNA 
 
1 cgcgtgggcg tgcctgtctg ctccggcagc accatgtcgc tcttgttcgt cagcatggcg 
       61 tgtgttgggt tcttcttgct gcagggggcc tggccacatg agggagtcca cagaaaacct 
      121 tccctcctgg cccacccagg tcccctggtg aaatcagaag agacagtcat cctgcaatgt 
      181 tggtcagatg tcatgtttga acacttcctt ctgcacagag aggggatgtt taacgacact 
      241 ttgcgcctca ttggagaaca ccatgatggg gtctccaagg ccaacttctc catcagtcgc 
      301 atgacgcaag acctggcagg gacctacaga tgctacggtt ctgttactca ctccccctat 
      361 caggtgtcag ctcccagtga ccctctggac atcgtgatca taggtctata tgagaaacct 
      421 tctctctcag cccagccggg ccccacggtt ctggcaggag agaatgtgac cttgtcctgc 
      481 agctcccgga gctcctatga catgtaccat ctatccaggg aaggggaggc ccatgaacgt 
      541 aggctccctg cagggcccaa ggtcaacgga acattccagg ctgactttcc tctgggccct 
      601 gccacccacg gagggaccta cagatgcttc ggctctttcc atgactctcc atacgagtgg 
      661 tcaaagtcaa gtgacccact gcttgtttct gtcacaggaa acccttcaaa tagttggcct 
      721 tcacccactg aaccaagctc caaaaccggt aacccccgac acctgcacat tctgattggg 
      781 acctcagtgg tcatcatcct cttcatcctc ctcttctttc tccttcatcg ctggtgctcc 
      841 aacaaaaaaa atgctgcggt aatggaccaa gagtctgcag gaaacagaac agcgaatagc 
      901 gaggactctg atgaacaaga ccctcaggag gtgacataca cacagttgaa tcactgcgtt 
      961 ttcacacaga gaaaaatcac tcgcccttct cagaggccca agacaccccc aacagatatc 
     1021 atcgtgtaca cggaacttcc aaatgctgag tccagatcca aagttgtctc ctgcccatga 
     1081 gcaccacagt caggccttga gggcgtcttc tagggagaca acagccctgt ctcaaaaccg 
     1141 ggttgccagc tcccatgtac cagcagctgg aatctgaagg catgagtctg catcttaggg 
     1201 catcgatctt cctcacacca caaatctgaa tgtgcctctc acttgcttac aaatgtctaa 
     1261 ggtccccact gcctgctgga gaaaaaacac actcctttgc ttagcccaca gttctccatt 
     1321 tcacttgacc cctgcccacc tctccaacct aactggctta cttcctagtc tacttgaggc 
     1381 tgcaatcaca ctgaggaact cacaattcca aacatacaag aggctccctc ttaacgcagc 
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     1441 acttagacac gtgttgttcc accttccctc atgctgttcc acctcccctc agactagctt 
     1501 tcagtcttct gtcagcagta aaacttatat attttttaaa ataacttcaa tgtagttttc 




Homo sapiens killer cell immunoglobulin-like receptor, two domains, 
long cytoplasmic tail, 2 (KIR2DL2), mRNA 
 
1 gcacagacag caccatgtcg ctcatggtcg tcagcatggc gtgtgttggg ttcttcttgc 
       61 tgcagggggc ctggccacat gagggagtcc acagaaaacc ttccctcctg gcccacccag 
      121 gtcgcctggt gaaatcagaa gagacagtca tcctgcaatg ttggtcagat gtcaggtttg 
      181 agcacttcct tctgcacaga gaagggaagt ttaaggacac tttgcacctc attggagagc 
      241 accatgatgg ggtctccaaa gccaacttct ccatcggtcc catgatgcaa gaccttgcag 
      301 ggacctacag atgctacggt tctgttactc actcccccta tcagttgtca gctcccagtg 
      361 accctctgga catcgtcatc acaggtctat atgagaaacc ttctctctca gcccagccgg 
      421 gccccacggt tctggcagga gagagcgtga ccttgtcctg cagctcccgg agctcctatg 
      481 acatgtacca tctatccagg gagggggagg cccatgaatg taggttctct gcagggccca 
      541 aggtcaacgg aacattccag gccgactttc ctctgggccc tgccacccac ggaggaacct 
      601 acagatgctt cggctctttc cgtgactctc catacgagtg gtcaaactcg agtgacccac 
      661 tgcttgtttc tgtcatagga aacccttcaa atagttggcc ttcacccact gaaccaagct 
      721 ctaaaaccgg taacccccga cacctgcaca ttctgattgg gacctcagtg gtcatcatcc 
      781 tcttcatcct cctcttcttt ctccttcatc gctggtgctc caacaaaaaa aatgctgcgg 
      841 taatggacca agagtctgca gggaacagaa cagcgaatag cgaggactct gatgaacaag 
      901 accctcagga ggtgacatac acacagttga atcactgcgt tttcacacag agaaaaatca 
      961 ctcgcccttc tcagaggccc aagacacccc caacagatat catcgtgtac gcggaacttc 
     1021 caaatgctga gtccagatcc aaagttgtct cctgcccatg agcaccacag tcaggccttg 
     1081 agggcgtctt ctagggagac aacagccctg tctcaaaacc gggttgccag ctcccatgta 
     1141 ccagcagctg gaatctgaag gcatgagtct gcatcttagg gcatcgctct tcctcacacc 
     1201 acaaatctga atgtgcctct cacttgctta caaatgtcta aggtccccac tgcctgctgg 
     1261 agaaaaaaca cactcctttg cttagcccac agttctccat ttcacttgac ccctgcccac 
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     1321 ctctccaacc taactggctt acttcctagt ctacttgagg ctgcaatcac actgaggaac 
     1381 tcacaattcc aaacatacaa gaggctccct cttaacgcag cacttagaca cgtgttgttc 
     1441 caccttccct catgctgttc cacctcccct cagactagct ttcagtcttc tgtcagcagt 
     1501 aaaacttata tattttttaa aataacttca atgtagtttt ccatccttca aataaacatg 
     1561 tctgccccca tg 
 
 
KIR2DL3 (AF022048)  
Homo sapiens natural killer cell inhibitory receptor KIR2DL3 variant 
mRNA, complete cds 
 
1 atgtcgctca tggtcgtcag catggcgtgt gttgggttct tcttgctgca gggggcctgg 
       61 ccacatgagg gagtccacag aaaaccttcc ctccgggccc acccaggtcc cctggtgaaa 
      121 tcagaagaga cagtcatcct gcaatgttgg tcagatgtca ggtttgagca cttccttctg 
      181 cacagagaag ggaagtttaa ggacactttg cgcctcattg gagagcacca tgatggggtc 
      241 tccaaggcca acttctccat cggtcccatg atgcaagacc ttgcagggac ctacagatgc 
      301 tacggttctg ttactcactc cccctatcag ttgtcagctc ccagtgaccc tctggacatc 
      361 gtcatcacag gtctatatga gaaaccttct ctctcagccc agccgggccc cacggttctg 
      421 gcaggagaga gcgtgacctt gtcctgcagc tcccggagct cctatgacat gtaccatcta 
      481 tccagggagg gggaggccca tgaacgtagg ttctctgcag ggcccaaggt caacggaaca 
      541 ttccaggccg actttcctct gggccctgcc acccacggag ggacctacag atgcttcggc 
      601 tctttccgtg actctccata cgagtggtca aactcgagtg acccactgct tgtttctgtc 
      661 acaggaaacc cttcaaatag ttggccttca cccactgaac caagctccga aaccggtaac 
      721 cccagacacc tgcatgttct gattgggacc tcagtggtca tcatcctctt catcctcctc 
      781 ctcttctttc tccttcatcg ctggtgctgc aacaaaaaaa atgctgttgt aatggaccaa 
      841 gagcctgcag ggaacagaac agtgaacagg gaggactctg atgaacaaga ccctcaggag 
      901 gtgacatatg cacagttgaa tcactgcgtt ttcacacaga gaaaaatcac tcacccttct 
      961 cagaggccca agacaccccc aacagatatc atcgtgtaca cggaacttcc aaatgctgag 
     1021 ccctgatcca aagttgtctc ctgcccatga gcaccacagt caggccttga ggggatcttc 





KIR2DL4 (NM_002255)  
Homo sapiens killer cell immunoglobulin-like receptor, two domains, 
long cytoplasmic tail, 4 (KIR2DL4), mRNA 
 
1 gtcgagccga gtcactgcgt cctggcagca gaagctgcac catgtccatg tcacccacgg 
       61 tcatcatcct ggcatgtctt gggttcttct tggaccagag tgtgtgggca cacgtgggtg 
      121 gtcaggacaa gcccttctgc tctgcctggc ccagcgctgt ggtgcctcaa ggaggacacg 
      181 tgactcttcg gtgtcactat cgtcgtgggt ttaacatctt cacgctgtac aagaaagatg 
      241 gggtccctgt ccctgagctc tacaacagaa tattctggaa cagtttcctc attagccctg 
      301 tgaccccagc acacgcaggg acctacagat gtcgaggttt tcacccgcac tcccccactg 
      361 agtggtcggc acccagcaac cccctggtga tcatggtcac aggtctatat gagaaacctt 
      421 cgcttacagc ccggccgggc cccacggttc gcacaggaga gaacgtgacc ttgtcctgca 
      481 gctcccagag ctcctttgac atctaccatc tatccaggga gggggaagcc catgaactta 
      541 ggctccctgc agtgcccagc atcaatggaa cattccaggc cgacttccct ctgggtcctg 
      601 ccacccacgg agagacctac agatgcttcg gctctttcca tggatctccc tacgagtggt 
      661 cagacgcgag tgacccactg cctgtttctg tcacaggaaa cccttctagt agttggcctt 
      721 cacccactga accaagcttc aaaactggta tcgccagaca cctgcatgct gtgattaggt 
      781 actcagtggc catcatcctc ttcaccatcc ttcccttctt tctccttcat cgctggtgct 
      841 ccaaaaaaaa aaatgctgct gtaatgaacc aagagcctgc gggacacaga acagtgaaca 
      901 gggaggactc tgatgaacaa gaccctcagg aggtgacata cgcacagttg gatcactgca 
      961 ttttcacaca gagaaaaatc actggccctt ctcagaggag caagagaccc tcaacagata 
     1021 ccagcgtgtg tatagaactt ccaaatgctg agcccagagc gttatctcct gcccatgagc 
     1081 accacagtca ggccttgatg ggatcttcta gggagacaac agccctgtct caaacccagc 
     1141 ttgccagctc taatgtacca gcagctggaa tctgaaggcg tgagtctcca tcttagagca 
     1201 tcactcttcc tcacaccaca aatctggtgc ctgtctcttg cttaccaatg tctaaggtcc 
     1261 ccactgcctg ctgcagagaa aacacactcc tttgcttagc ccacaattct ctatttcact 
     1321 tgacccctgc ccacctctcc aacctaactg gcttacttcc tagtctactt gaggctgcaa 
     1381 tcacactgag gaactcacaa ttccaaacat acaagaggct ctctattaac acggcactta 
     1441 gacacgtgct gttccacctt ccctcgtgct gttccacctt tcctcagact atttttcagc 
     1501 cttctggcat cagcaaacct tataaaattt ttttgatttc agtgtagttc tctcctcttc 
  
113 
     1561 aaataaacat gtctgccttc aaaaaaaaaa aaaaaaaaaa aaaaaaaaa 
 
 
KIR2DL5 (AF217487)  
Homo sapiens killer cell Ig-like receptor KIR2DL5.3 (KIR2DL5.3) mRNA, 
complete cds 
 
1 ccgcctgtct gcaccggcag caccatgtcg ctcatggtcg tcagcatggc gtgtgttggg 
       61 ttcttcttgc tgcagggggc ctggccacat gagggtggtc aggacaagcc cttgctgtct 
      121 gcctggccca gcgctgtggt gcctcgagga ggacatgtga ctcttctgtg tcgctctcgt 
      181 cttgggttta ccatcttcag tctgtacaaa gaagatgggg tgcctgtccc tgagctctac 
      241 aacaaaatat tctggaagag catcctcatg ggccctgtga cccctgcaca cgcagggacc 
      301 tacagatgtc ggggttcaca cccacgctcc cccattgagt ggtcagcacc cagcaacccc 
      361 ctggtgatca tggtcacagg tctatttggg aaaccttcac tctcagccca gccgggcccc 
      421 acggttcgca caggagagaa cgtgaccttg tcctgcagct ccaggagctc atttgacatg 
      481 taccatctat ccagggaggg gagggcccat gaacctaggc tccctgcagt gcccagcgtc 
      541 aatggaacat tccaggctga ctttcctctg ggccctgcca cccacggagg gacctacaca 
      601 tgcttcggct ctctccatga ctcaccctat gagtggtcag acccgagtga cccactgctt 
      661 gtttctgtca caggaaactc ttcaagtagt tcatcttcac ccactgaacc aagctccaaa 
      721 actggtatcc gcagacacct gcacattctg attgggacct cagtggctat catcctcttc 
      781 atcatcctct tcttctttct ccttcattgc tgctgctcca acaaaaagaa tgctgctgta 
      841 atggaccaag agcctgccgg ggacagaaca gtgaacaggg aggactctga tgatcaagac 
      901 cctcaggagg tgacatatgc acagttggat cactgcgttt tcacacagac aaaaatcact 
      961 tccccttctc agaggcccaa gacacctcca acagatacca ccatgtacat ggaacttcca 
     1021 aatgctaagc caagatcatt gtctcctgcc cataagcacc acagtcaggc cttgagggga 
     1081 tcttctaggg agacaacagc cctgtctcaa aaccgggttg ctagctccca tgtaccagca 
     1141 gctggaatct gaaggcatca gtcttcatct taggggatcg ctcttcctca caccacaaat 
     1201 ctgaacatgc ctctctcttg cttacaaatg tctaaggtcc ccactgcctg ctggagagaa 
     1261 gacacactcc tttgcttagc ccacaattct ctatttcact tgacccctgc ccacctctcc 
     1321 aactgaactg gcttacttcc tagtctactt gaggctgcaa tcacactgag gaactcacaa 
     1381 ttccagacat acaagaggct ccctcttaac atggcactga gacacgtgct gttccacctt 
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Homo sapiens killer cell immunoglobulin-like receptor, two domains, 
short cytoplasmic tail, 1 (KIR2DS1), mRNA 
 
1 caccggcagc accatgtcgc tcacggtcgt cagcatggcg tgtgttgggt tcttcttgct 
       61 gcagggggcc tggccacatg agggagtcca cagaaaacct tccctcctgg cccacccagg 
      121 tcgcctggtg aaatcagaag agacagtcat cctgcaatgt tggtcagatg tcatgtttga 
      181 acacttcctt ctgcacagag aggggatgtt taacgacact ttgcgcctca ttggagaaca 
      241 ccatgatggg gtctccaagg ccaacttctc catcagtcgc atgaagcaag acctggcagg 
      301 gacctacaga tgctacggtt ctgttactca ctccccctat cagttgtcag ctcccagtga 
      361 ccctctggac atcgtgatca taggtctata tgagaaacct tctctctcag cccagccggg 
      421 ccccacggtt ctggcaggag agaatgtgac cttgtcctgc agctcccgga gctcctatga 
      481 catgtaccat ctatccaggg aaggggaggc ccatgaacgt aggctccctg cagggaccaa 
      541 ggtcaacgga acattccagg ccaactttcc tctgggccct gccacccatg gagggaccta 
      601 cagatgcttc ggctctttcc gtgactctcc atacgagtgg tcaaagtcaa gtgacccact 
      661 gcttgtttct gtcacaggaa acccttcaaa tagttggcct tcacccactg aaccaagctc 
      721 cgaaaccggt aaccccagac acctacatgt tctgattggg acctcagtgg tcaaaatccc 
      781 tttcaccatc ctcctcttct ttctccttca tcgctggtgc tccgacaaaa aaaatgctgc 
      841 tgtaatggac caagagcctg cagggaacag aacagtgaac agcgaggatt ctgatgaaca 
      901 agaccatcag gaggtgtcat acgcataatt ggatcactgt gttttcacac agagaaaaat 
      961 cactcgccct tctgagaggc ccaagacacc cccaacagat accagcatgt acatagaact 
     1021 tccaaatgct gagcccagat ccaaagttgt cttctgtcca cgagcaccac agtcaggcct 
     1081 tgaggggatc ttctagggag a 
 
 
KIR2DS2 (NM_012312)  
Homo sapiens killer cell immunoglobulin-like receptor, two domains, 




1 tgtctgcaca gacagcacca tgtcgctcat ggtcgtcagc atggcgtgtg ttgggttctt 
       61 cttgctgcag ggggcctggc cacatgaggg agtccacaga aaaccttccc tcctggccca 
      121 cccaggtccc ctggtgaaat cagaagagac agtcatcctg caatgttggt cagatgtcag 
      181 gtttgagcac ttccttctgc acagagaggg gaagtataag gacactttgc acctcattgg 
      241 agagcaccat gatggggtct ccaaggccaa cttctccatc ggtcccatga tgcaagacct 
      301 tgcagggacc tacagatgct acggttctgt tactcactcc ccctatcagt tgtcagctcc 
      361 cagtgaccct ctggacatcg tcatcacagg tctatatgag aaaccttctc tctcagccca 
      421 gccgggcccc acggttttgg caggagagag cgtgaccttg tcctgcagct cccggagctc 
      481 ctatgacatg taccatctat ccagggaggg ggaggcccat gaacgtaggt tctctgcagg 
      541 gcccaaggtc aacggaacat tccaggccga ctttcctctg ggccctgcca cccacggagg 
      601 aacctacaga tgcttcggct ctttccgtga ctctccctat gagtggtcaa actcgagtga 
      661 cccactgctt gtttctgtca caggaaaccc ttcaaatagt tggccttcac ccactgaacc 
      721 aagctccaaa accggtaacc ccagacacct gcatgttctg attgggacct cagtggtcaa 
      781 aatccctttc accatcctcc tcttctttct ccttcatcgc tggtgctcca acaaaaaaaa 
      841 tgctgctgta atggaccaag agcctgcagg gaacagaaca gtgaacagcg aggattctga 
      901 tgaacaagac catcaggagg tgtcatacgc ataattggat cactgtgttt tcacacagag 
      961 agaaatcact cgcccttctg agaggcccaa gacaccccca acagatacca gcatgtacat 
     1021 agaacttcca aatgctgagc ccagatccaa agttgtcttc tgtccacgag caccacagtc 
     1081 aggccttgag gggatcttct agggagacaa cagccctgtc tcaaaaccgg gttgccagct 
     1141 cccatgtacc agcagctgga atctgaaggc atcagtcttc atcttagggc atcgctcttc 
     1201 ctcacaccac gaatctgaac atgcctctct cttgcttaca aatgtctaag gtccccactg 
     1261 cctgctggag agaaaacaca ctcctttgct tagcccacaa ttctccattt cacttgaccc 
     1321 ctgcccacct ctccaaccta actagcttac ttcctagtct acctgaggct gcaatcacac 
     1381 tgaggaactc acaattccaa acatacaaga ggctccctct taacacagca cttagacacg 
     1441 tgctgttcca cctcccttca gactatcttt cagccttctg ccagcagtaa aacttataaa 




Homo sapiens killer cell immunoglobulin-like receptor, two domains, short 
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cytoplasmic tail, 3 (KIR2DS3), mRNA 
 
1 ccggcagcac catgtcgctc atggtcatca gcatggcatg tgttgggttc ttctggctgc 
       61 agggggcctg gccacatgag ggattccgca gaaaaccttc cctcctggcc cacccaggtc 
      121 gcctggtgaa atcagaagag acagtcatcc tgcaatgttg gtcagatgtc atgtttgagc 
      181 acttccttct gcacagagag gggacgttta acgacacttt gcgcctcatt ggagagcaca 
      241 ttgatggggt ctccaaggcc aacttctcca tcggtcgcat gaggcaagac ctggcaggga 
      301 cctacagatg ctacggttct gttcctcact ccccctatca gttttcagct cccagtgacc 
      361 ctctggacat cgtgatcaca ggtctatatg agaaaccttc tctctcagcc cagccgggcc 
      421 ccacggttct ggcaggagag agcgtgacct tgtcctgcag ctcctggagc tcctatgaca 
      481 tgtaccatct atccacggag ggggaggccc atgaacgtag gttctctgca gggcccaagg 
      541 tcaacggaac attccaggcc gactttcctc tgggccctgc cacccaagga ggaacctaca 
      601 gatgcttcgg ctctttccat gactctccct acgagtggtc aaagtcaagt gacccactgc 
      661 ttgtttctgt cacaggaaac ccttcaaata gttggccttc acccactgaa ccaagctcca 
      721 aaaccggtaa ccccagacac ctacacgttc tgattgggac ctcagtggtc aaactccctt 
      781 tcaccatcct cctcttcttt ctccttcatc gctggtgctc cgacaaaaaa aatgcatctg 
      841 taatggacca agggcctgcg gggaacagaa cagtgaacag ggaggattct gacgaacagg 
      901 accatcagga ggtgtcatac gcataattgg atcactgtgt tttcacacag agaaaaatca 
      961 ctcccccttc tcagaggccc aagacacccc caacagatag cagcatgtac atagaacttc 
     1021 caaatgctga gtccagatcc aaagctgtct tctgtccacg agcaccacag tcaggccttg 
     1081 aggggatctt ctagggagac aacagccctg tct 
 
 
KIR2DS4 (AY388472)  
Homo sapiens natural killer cell Ig-like receptor KIR2DS4 (KIR2DS4) 
mRNA, KIR2DS4*00101 allele, complete cds 
 
1 gagctggggc gcggccgcct gtctgcaccg gcagcaccat gtcgctcatg gtcatcatca 
       61 tggcgtgtgt tgggttcttc ttgctgcagg gggcctggcc acaggaggga gtccacagaa 
      121 aaccttcctt cctggccctc ccaggtcacc tggtgaaatc agaagagaca gtcatcctgc 
      181 aatgttggtc ggatgtcatg tttgagcact tccttctgca cagagagggg aagtttaaca 
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      241 acactttgca cctcattgga gagcaccatg atggggtttc caaggccaac ttctccattg 
      301 gtcccatgat gcctgtcctt gcaggaacct acagatgcta cggttctgtt cctcactccc 
      361 cctatcagtt gtcagctccc agtgaccctc tggacatggt gatcataggt ctatatgaga 
      421 aaccttctct ctcagcccag ccgggcccca cggttcaggc aggagagaat gtgaccttgt 
      481 cctgcagctc ccggagctcc tatgacatgt accatctatc cagggaaggg gaggcccatg 
      541 aacgtaggct ccctgcagtg cgcagcatca acggaacatt ccaggccgac tttcctctgg 
      601 gccctgccac ccacggaggg acctacagat gcttcggctc tttccgtgac gctccctacg 
      661 agtggtcaaa ctcgagtgat ccactgcttg tttccgtcac aggaaaccct tcaaatagtt 
      721 ggccttcacc cactgaacca agctccaaaa ccggtaaccc cagacaccta catgttctga 
      781 ttgggacctc agtggtcaaa atccctttca ccatcctcct cttctttctc cttcatcgct 
      841 ggtgctccga caaaaaaaat gctgctgtaa tggaccaaga gcctgcaggg aacagaacag 
      901 tgaacagcga ggattctgat gaacaagacc atcaggaggt gtcatacgca taattggatc 
      961 actgtgtttt cacacagaga aaaatcactc gcccttctga gaggcccaag acacccccaa 
     1021 cagataccag catgtacata gaacttccaa atgctgagcc cagatccaaa gttgtcttct 
     1081 gtccacgagc accacagtca ggccttgagg ggatcttcta gggagacaac agccctgtct 
     1141 caaaaccggg ttgccagctc ccatgtacca gcagctggaa tctgaaggca tcagtcttca 
     1201 tcttagggca tcgctcttcc tcacaccacg aatctgaaca tgcctctctc ttgcttacaa 
     1261 atgtctaagg tccccactgc ctgctggaga gaaaacacac tcctttgctt agcccacaat 
     1321 tctccatttc acttgacccc tgcccacctc tccaacctaa ctggcttact tctagtctac 




Homo sapiens killer cell immunoglobulin-like receptor, two domains, 
short cytoplasmic tail, 5 (KIR2DS5), mRNA 
 
1 ccggcagcac catgttgctc atggtcatca gcatggcgtg tgttgcgttc ttcttgctgc 
       61 agggggcctg gccacatgag ggattccgca gaaaaccttc cctcctggcc cacccaggtc 
      121 ccctggtgaa atcagaagag acagtcatcc tgcaatgttg gtcagatgtc atgtttgagc 
      181 acttccttct gcacagagag gggacgttta accacacttt gcgcctcatt ggagagcaca 
      241 ttgatggggt ctccaagggc aacttctcca tcggtcgcat gacacaagac ctggcaggga 
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      301 cctacagatg ctacggttct gttactcact ccccctatca gttgtcagcg cccagtgacc 
      361 ctctggacat cgtgatcaca ggtctatatg agaaaccttc tctcccagcc cagccgggcc 
      421 ccacggttct ggcaggagag agcgtgacct tgtcctgcag ctcccggagc tcctatgaca 
      481 tgtaccatct atccagggaa ggggaggccc atgaacgtag gctccctgca gggcccaagg 
      541 tcaacagaac attccaggcc gactctcctc tggaccctgc cacccacgga ggggcctaca 
      601 gatgcttcgg ctctttccgt gactctccat acgagtggtc aaagtcaagt gacccactgc 
      661 ttgtttctgt cacaggaaac tcttcaaata gttggccttc acccactgaa ccaagctccg 
      721 aaaccggtaa ccccagacac ctacacgttc tgattgggac ctcagtggtc aaactccctt 
      781 tcaccatcct cctcttcttt ctccttcatc gctggtgctc caacaaaaaa aatgcatctg 
      841 taatggacca agggcctgcg gggaacagaa cagtgaacag ggaggattct gatgaacagg 
      901 accatcagga ggtgtcatac gcataattgg atcactgtgt tttcacacag agaaaaatca 
      961 ctcccccttc tcagaggccc aagacacccc caacagatac cagcatgtac atagaacttc 
     1021 caaatgctga gtccagatcc aaagctgtct tctgtccacg agcaccacag tcaggccttg 
     1081 aggggatctt ctagggagac aacagccctg tctcaaaacc gggttgccag ctcccatgta 
     1141 cctgcggctg gaatctgaag gcatcagtct tcatcttagg ggatcgctct tcctcaaacc 
     1201 acgaatctga acatgcctct ctcctgctta caaatgtcta aggtccccac tgcctgctgg 
     1261 agagaaaaca cactcctttg cttagcccac aattctccat ttcacttgac ccctgcccac 
     1321 ctctccaacc taactggctt acttcctggt ctacttgagg ctgcaatcac actgaggaac 
     1381 tcacaattcc aaacatacaa gaggctccct cttaacacag cacttagaca cgtgctgttc 




Homo sapiens killer cell immunoglobulin-like receptor, three domains, 
long cytoplasmic tail, 1 (KIR3DL1), mRNA 
 
1 ccacgcgtcc ggcaccggca gcaccatgtt gctcatggtc gtcagcatgg cgtgtgttgg 
       61 gttcttcttg gtccagaggg ccggtccaca cgtgggtggt caggacaagc ccttcctgtc 
      121 tgcctggccc agcgctgtgg tgcctcgagg aggacacgtg actcttcggt gtcactatcg 
      181 tcataggttt aacaatttca tgctatacaa agaagacaga atccacgttc ccatcttcca 
      241 tggcagatta ttccaggaga gcttcaacat gagccctgtg accacagcac atgcagggaa 
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      301 ctacacatgt cggggttcac acccacactc ccccactggg tggtcggcac ccagcaaccc 
      361 cgtggtgatc atggtcacag gaaaccacag aaaaccttcc ctcctggccc acccaggtcc 
      421 cctggtgaaa tcaggagaga gagtcatcct gcaatgttgg tcagatatca tgtttgagca 
      481 cttctttctg cacaaagagg ggatctctaa ggacccctca cgcctcgttg gacagatcca 
      541 tgatggggtc tccaaggcca atttctccat cggtcccatg atgcttgccc ttgcagggac 
      601 ctacagatgc tacggttctg ttactcacac cccctatcag ttgtcagctc ccagtgatcc 
      661 cctggacatc gtggtcacag gtccatatga gaaaccttct ctctcagccc agccgggccc 
      721 caaggttcag gcaggagaga gcgtgacctt gtcctgcagc tcccggagct cctatgacat 
      781 gtaccatcta tccagggagc ggggagccca tgaacgtagg ctccctgcag tgcgcaaggt 
      841 caacagaaca ttccaggcag atttccctct gggccctgcc acccacggag ggacctacag 
      901 atgcttcggc tctttccgtc actctcccta cgagtggtca gacccgagtg acccactgct 
      961 tgtttctgtc acaggaaacc cttcaagtag ttggccttca cccacagaac caagctccaa 
     1021 atctggtaac cccagacacc tgcacattct gattgggacc tcagtggtca tcatcctctt 
     1081 catcctcctc ctcttctttc tccttcatct ctggtgctcc aacaaaaaaa atgctgctgt 
     1141 aatggaccaa gagcctgcag ggaacagaac agccaacagc gaggactctg atgaacaaga 
     1201 ccctgaggag gtgacatacg cacagttgga tcactgcgtt ttcacacaga gaaaaatcac 
     1261 tcgcccttct cagaggccca agacaccccc tacagatacc atcttgtaca cggaacttcc 
     1321 aaatgctaag cccagatcca aagttgtctc ctgcccatga gcaccacagt caggccttga 
     1381 ggacgtcttc tagggagaca acagccctgt ctcaaaaccg agttgccagc tcccatgtac 
     1441 cagcagctgg aatctgaagg cgtgagtctt catcttaggg catcgctcct cctcacgcca 
     1501 caaatctggt gcctctctct tgcttacaaa tgtctaggtc cccactgcct gctggaaaga 
     1561 aaacacactc ctttgcttag cccacagttc tccatttcac ttgacccctg cccacctctc 
     1621 caacctaact ggcttacttc ctagtctact tgaggctgca atcacactga ggaactcaca 
     1681 attccaaaca tacaagaggc tccctcttga cgtggcactt acccacgtgc tgttccacct 
     1741 tccctcatgc tgtttcacct ttcttcggac tattttccag ccttctgtca gcagtgaaac 
     1801 ttataaaatt ttttgtgatt tcaatgtagc tgtctcctct tcaaataaac atgtctgccc 




Homo sapiens killer cell immunoglobulin-like receptor, three domains, long 
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cytoplasmic tail, 2 (KIR3DL2), mRNA 
 
1 ccatgtcgct cactgtcgtc agcatggcgt gcgttgggtt cttcttgctg cagggggcct 
       61 ggccactcat gggtggtcag gacaaaccct tcctgtctgc ccggcccagc actgtggtgc 
      121 ctcgaggagg acacgtggct cttcagtgtc actatcgtcg tgggtttaac aatttcatgc 
      181 tgtacaaaga agacagaagc cacgttccca tcttccacgg cagaatattc caggagagct 
      241 tcatcatggg ccctgtgacc ccagcacatg cagggaccta cagatgtcgg ggttcacgcc 
      301 cacactccct cactgggtgg tcggcaccca gcaaccccct ggtgatcatg gtcacaggaa 
      361 accacagaaa accttccctc ctggcccacc cagggcccct gctgaaatca ggagagacag 
      421 tcatcctgca atgttggtca gatgtcatgt ttgagcactt ctttctgcac agagatggga 
      481 tctctgagga cccctcacgc ctcgttggac agatccatga tggggtctcc aaggccaact 
      541 tctccatcgg tcccttgatg cctgtccttg caggaaccta cagatgttat ggttctgttc 
      601 ctcactcccc ctatcagttg tcagctccca gtgaccccct ggacatcgtg atcacaggtc 
      661 tatatgagaa accttctctc tcagcccagc cgggccccac ggttcaggca ggagagaacg 
      721 tgaccttgtc ctgtagctcc tggagctcct atgacatcta ccatctgtcc agggaagggg 
      781 aggcccatga acgtaggctc cgtgcagtgc ccaaggtcaa cagaacattc caggcagact 
      841 ttcctctggg ccctgccacc cacggaggga cctacagatg cttcggctct ttccgtgccc 
      901 tgccctgcgt gtggtcaaac tcaagtgacc cactgcttgt ttctgtcaca ggaaaccctt 
      961 caagtagttg gccttcaccc acagaaccaa gctccaaatc tggtatctgc agacacctgc 
     1021 atgttctgat tgggacctca gtggtcatct tcctcttcat cctcctcctc ttctttctcc 
     1081 tttatcgctg gtgctccaac aaaaagaatg ctgctgtaat ggaccaagag cctgcggggg 
     1141 acagaacagt gaataggcag gactctgatg aacaagaccc tcaggaggtg acgtacgcac 
     1201 agttggatca ctgcgttttc atacagagaa aaatcagtcg cccttctcag aggcccaaga 
     1261 cacccctaac agataccagc gtgtacacgg aacttccaaa tgctgagccc agatccaaag 
     1321 ttgtctcctg cccacgagca ccacagtcag gtcttgaggg ggttttctag ggagacaaca 
     1381 gccctgtctc aaaaccaggt tgccagatcc aatgaaccag cagctggaat ctgaaggcat 
     1441 cagtctgcat cttaggggat cgctcttcct cacaccacga atctgaacat gcctctctct 
     1501 tgcttacaaa tgcctaaggt cgccactgcc tgctgcagag aaaacacact cctttgctta 
     1561 gcccacaagg tatctatttc acttgacccc tgcccacctc tccaacctaa ctggcttact 
     1621 tcctagtcct acttgaggct gcaatcacac tgaggaactc acaattccaa acatacaaga 
     1681 ggctccctct taacacggca cttacacact tgctgttcca ccttccctca tgctgttcca 
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     1741 cctcccctca gactatcttt cagccttctg tcatcagtaa aatttataaa ttttttttat 




Homo sapiens killer cell immunoglobulin-like receptor, three domains, 
long cytoplasmic tail, 3 (KIR3DL3), mRNA 
 
1 gtctgcaccg gcagcaccat gtcgctcatg gtcgtcagca tggcgtgtgt tgggttcttc 
       61 ttgctggagg ggccctggcc acatgtgggt ggtcaggaca agcccttcct ctctgcctgg 
      121 cccggcactg tggtgtctga aggacaacat gtgactcttc agtgtcgctc tcgtcttggg 
      181 tttaacgaat tcagtctgtc caaagaagac gggatgcctg tccctgagct ctacaacaga 
      241 atattccgga acagctttct catgggccct gtgaccccag cacatgcagg gacctacaga 
      301 tgttgcagtt cacacccaca ctcccccact gggtggtcgg cacccagcaa ccctgtggtg 
      361 atcatggtca cgggagtcca cagaaaacct tccctcctgg cccacccagg tcccctggtg 
      421 aaatcgggag agacggtcat cctgcaatgt tggtcagatg tcaggtttga gcgcttcctt 
      481 ctgcacagag aggggatcac tgaggacccc ttgcgcctcg ttggacagct ccacgatgcg 
      541 ggttcccagg tcaactattc catgggtccc atgacacctg cccttgcagg gacctacaga 
      601 tgctttggtt ctgtcactca cttaccctat gagttgtcgg ctcccagtga ccctctggac 
      661 atcgtggtcg taggtctata tgggaaacct tctctctcag cccagccggg ccccacggtt 
      721 caggcaggag agaatgtgac cttgtcctgc agctcccgga gcttgtttga catttaccat 
      781 ctatccaggg aggcagaggc cggtgaactt aggctcactg cggtgctgag ggtcaatgga 
      841 acattccagg ccaacttccc tctgggccct gtgacccacg gagggaacta cagatgcttc 
      901 ggctctttcc gtgccctgcc ccacgcgtgg tcagacccga gtgacccact gcccgtttct 
      961 gtcacaggta actccagaca cctgcacgtt ctgattggga cctcagtggt catcatcccc 
     1021 tttgctatcc tcctcttctt tctccttcat cgctggtgtg ccaacaaaaa gaatgctgtt 
     1081 gtaatggacc aagagcctgc agggaacaga acagtgaaca gggaggactc tgatgaacaa 
     1141 gaccctcagg aggtgacata cgcacagttg aatcactgcg ttttcacaca gagaaaaatc 
     1201 actcgccctt ctcagaggcc caagacaccc ccaacagata ccagcgtgta acacggaact 
     1261 tccaaatgct gagcgcagat ccaaagttgt cttctgtcca ctagcaccac agtcaggcct 
     1321 tgatgggatc ttctagggag acaatagccc tgtctcaaaa ccgggttgcc agctcccatg 
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     1381 taccagcagc tggactctga aggcgtgagt ctgcatctta gggcatcgct cttcctcaca 
     1441 ccacgaatct gaacatgcct ctctcttgct tacaaatgtc taaggtcccc actgcctgct 
     1501 ggagagaaaa cacacttgct tagcccacaa ttctccattt cacttgaccc ctgcccacct 
     1561 ctccaaccta actggcttac ttcctagtct acttgaggct gcgatcacac tgaggaactc 
     1621 acaattccaa acatataaga ggctccctct taacacggca cttagatacg tgctattcca 




Homo sapiens natural killer cell receptor KIR3DS1 variant mRNA, 
complete cds 
 
1 caccggcagc accatgttgc tcatggtcgt cagcatggcg tgtgttgggt tgttcttggt 
       61 ccagagggcc ggtccacaca tgggtggtca ggacaagccc ttcctgtctg cctggcccag 
      121 cgctgtggtg cctcgcggag gacacgtgac tcttcggtgt cactatcgtc ataggtttaa 
      181 caatttcatg ctatacaaag aagacagaat ccacgttccc atcttccatg gcagaatatt 
      241 ccaggagggc ttcaacatga gccctgtgac cacagcacat gcagggaact acacatgtcg 
      301 gggttcacac ccacactccc ccactgggtg gtcggcaccc agcaacccca tggtgatcat 
      361 ggtcacagga aaccacagaa aaccttccct cctggcccac ccaggtcccc tggtgaaatc 
      421 aggagagaga gtcatcctgc aatgttggtc agatatcatg tttgagcact tctttctgca 
      481 caaagagtgg atctctaagg acccctcacg cctcgttgga cagatccatg atggggtctc 
      541 caaggccaat ttctccatcg gttccatgat gcgtgccctt gcagggacct acagatgcta 
      601 cggttctgtt actcacaccc cctatcagtt gtcagctccc agtgatcccc tggacatcgt 
      661 ggtcacaggt ctatatgaga aaccttctct ctcagcccag ccgggcccca aggttcaggc 
      721 aggagagagc gtgaccttgt cctgtagctc ccggagctcc tatgacatgt accatctatc 
      781 cagggagggg ggagcccatg aacgtaggct ccctgcagtg cgcaaggtca acagaacatt 
      841 ccaggcagat ttccctctgg gccctgccac ccacggaggg acctacagat gcttcggctc 
      901 tttccgtcac tctccctacg agtggtcaga cccgagtgac ccactgcttg tttctgtcac 
      961 aggaaaccct tcaagtagtt ggccttcacc cacagaacca agctccaaat ctggtaacct 
     1021 cagacacctg cacattctga ttgggacctc agtggtcaaa atccctttca ccatcctcct 
     1081 cttctttctc cttcatcgct ggtgctccaa caaaaaaaaa tgctgctgta atggaccaag 
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     1141 agcctgcagg gaacagaagt gaacagcgag gattctgatg aacaagacca tcaggaggtg 
     1201 tcatacgcat aattggaaca ctgtgttttc acacagagaa aaatcactcg cccttctcag 
     1261 aggcccaaga cacccccaac agataccagc atgtacatag aacttccaaa tgctgagccc 
     1321 agatccaaag ttgtcttctg tccacgagca ccacagtcag gccttgaggg gatcttctag 




Homo sapiens killer cell Ig-like receptor (KIR48) gene, KIR48b 
variant, exon 3 
 
1 ctgcatgggc agggcgccaa ataacatcct gtgcgctgct gagctgagct ggggcgcggc 
       61 cgcctgtctg caccggcagc accatgtcgc tcatggtcgt cagcatggcg tgtgttggtg 
      121 agtcctggaa aggaatagag ggagggagtg ccacatcctc ctctctaagg tggcgcctcc 
      181 ttctccccca ggtggtcagg acaagccctt cctctctgcc tggcccagcc ccgtggtgtc 
      241 tgaaggagaa catgtggctc ttcagtgtcg ctctcgtctt gggtttaacg aattcagtct 
      301 gtccaaagaa gacgggatgc ctgtccctga gctctacaac agagtattcc gaaacaccgt 
      361 tttcataggc cctgtgaccc cagcacatgc agggacctac agatgtcggg gttcacaccc 
      421 acacttcctc actgggtggt cagcacccag caaccccctg gtgatcatgg tcacaggtca 
      481 gagggctcct gtctgggatt ctccttgtcc cacctcctga gtcccagagc ttctggtggg 
      541 agtgtccacc agcgtcccat catccagacc ctaactgtat ttgggataaa aggggattga 
      601 atacagggaa atgggtgctg tggtggaaag aataattgtc cccaatgatg actgcattct 
      661 aatccctgca gtctgtgact atttatgtta taggggaagg cactgaaggg gaagatggag 
      721 ctcaggttgt tgagttgacc ttgagatggg gagacagcct ggactgtcct gctgggctca 
      781 gtgtaatcac aagggtgcac atgagaggag aaggaagagg ggagtggcga ttagagcagt 
      841 gcaatggaag tctccatcag ctttgaaggt ggaggaaggc catgagccat gaatgcaggt 
      901 ggcctataga ggctggaaaa gtcaaggaac tgattctcct gggtctccag agggaacgca 






Homo sapiens killer cell immunoglobulin-like receptor, two domains, 
short cytoplasmic tail, 4 (KIR2DS4), transcript variant 2, mRNA 
 
1 catggcgtgt gttgggttct tcttgctgca gggggcctgg ccacaggagg gagtccacag 
       61 aaaaccttcc ttcctggccc tcccaggtca cctggtgaaa tcagaagaga cagtcatcct 
      121 gcaatgttgg tcggatgtca tgtttgagca cttccttctg cacagagagg ggaagtttaa 
      181 caacactttg cacctcattg gagagcacca tgatggggtt tccaaggcca acttctccat 
      241 tggtcccatg atgcctgtcc ttgcaggaac ctacagatgc tacggttctg ttcctcactc 
      301 cccctatcag ttgtcagctc ccagtgaccc tctggacatg gtgatcatag gtctatatga 
      361 gaaaccttct ctctcagccc agccgggccc cacggttcag gcaggagaga atgtgacctt 
      421 gtcctgcagc tccatctatc cagggaaggg gaggcccatg aacgtaggct ccctgcagtg 
      481 cgcagcatca acggaacatt ccaggccgac tttcctctgg gccctgccac ccacggaggg 
      541 acctacagat gcttcggctc tttccgtgac gctccctacg agtggtcaaa ctcgagtgat 
      601 ccactgcttg tttccgtcac aggaaaccct tcaaatagtt ggccttcacc cactgaacca 
      661 agctccaaaa ccggtaaccc cagacaccta catgttctga ttgggacctc agtggtcaaa 
      721 atccctttca ccatcctcct cttctttctc cttcatcgct ggtgctccga caaaaaaaat 
      781 gctgctgtaa tggaccaaga gcctgcaggg aacagaacag tgaacagcga ggattctgat 
      841 gaacaagacc atcaggaggt gtcatacgca taattggatc actgtgtttt cacacagaga 
      901 aaaatcactc gcccttctga gaggcccaag acacccccaa cagataccag catgtacata 
      961 gaacttccaa atgctgagcc cagatccaaa gttgtcttct gtccacgagc accacagtca 
     1021 ggccttgagg ggatcttcta gggagacaac agccctgtct caaaaccggg ttgccagctc 
     1081 ccatgtacca gcagctggaa tctgaaggca tcagtcttca tcttagggca tcgctcttcc 
     1141 tcacaccacg aatctgaaca tgcctctctc ttgcttacaa atgtctaagg tccccactgc 
     1201 ctgctggaga gaaaacacac tcctttgctt agcccacaat tctccatttc acttgacccc 
     1261 tgcccacctc tccaacctaa ctggcttact tcctagtcta cctgaggctg caatcacact 
     1321 gaggaactca caattccaaa catacaagag gctgcctctt aacacagcac ttagacacgt 
     1381 gctgttccac ctcccttcag actatctttc agccttctgc cagcagtaaa acttataaat 








Fig 7.1 Validation of PCR primers and PCR-SSP typing system. KIR gene-specific primers and PCR products of each KIR gene 
were submitted to BLAST and matched with sequences from the database. Forward primer sequences are underlined and reverse 
primer sequences are italized.  
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